Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech
Coverage 246,630 Raw stories ingested 38,037 rewritten in CS_CZ • 2 to rewrite (last 7 days).
Agents 7 Live Pipeline agents
  • FMP Stock News Fetch every minute running now
  • FMP Forex News Fetch every 5 min 4m ago
  • CoinGecko News Fetch every 5 min 4m ago
  • FIO Stock News Fetch every 10 min 5m ago
  • Patria Stock News Fetch every 10 min 5m ago
  • Editorial rewrite Rewrite every minute 1m ago
  • Asset sync Assets every 1 hour 38m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-10-27 14:39 1d ago
2026-10-27 05:50 1d ago
James Foster prodal akcie společnosti Charles River za 8 414 700 USD
CRL Charles River Laboratories
FMP Stock News 72
Original source text
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) Director James Foster sold 24,042 shares of the company’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $350.00, for a total transaction of $8,414,700.00. Following the completion of the sale, the director directly owned 31,596 shares of the company’s stock, valued at $11,058,600. The trade was a 43.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Charles River Laboratories International Price Performance
NYSE CRL opened at $356.76 on Tuesday. The stock has a market capitalization of $17.03 billion, a P/E ratio of -73.56, a P/E/G ratio of 3.23 and a beta of 1.40. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.04 and a current ratio of 1.35. The business’s fifty day moving average is $295.70 and its two-hundred day moving average is $219.36. Charles River Laboratories International, Inc. has a 1 year low of $146.20 and a 1 year high of $357.77.

Charles River Laboratories International (NYSE:CRL – Get Free Report) last announced its earnings results on Wednesday, August 5th. The medical research company reported $3.02 EPS for the quarter, topping the consensus estimate of $2.77 by $0.25. Charles River Laboratories International had a negative net margin of 5.96% and a positive return on equity of 15.75%. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $980.53 million. During the same period last year, the company posted $3.12 earnings per share. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. Charles River Laboratories International has set its FY 2026 guidance at 11.150-11.450 EPS. On average, research analysts forecast that Charles River Laboratories International, Inc. will post 11.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Charles River Laboratories International
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Physician Wealth Advisors Inc. grew its holdings in shares of Charles River Laboratories International by 127.9% during the third quarter. Physician Wealth Advisors Inc. now owns 98 shares of the medical research company’s stock worth $29,000 after purchasing an additional 55 shares during the last quarter. Continuum Advisory LLC acquired a new position in Charles River Laboratories International during the 2nd quarter worth $30,000. IFP Advisors Inc increased its stake in shares of Charles River Laboratories International by 182.8% in the 3rd quarter. IFP Advisors Inc now owns 164 shares of the medical research company’s stock valued at $48,000 after buying an additional 106 shares during the period. Compass Wealth Management LLC acquired a new stake in Charles River Laboratories International in the third quarter worth about $69,000. Finally, Activest Wealth Management grew its position in shares of Charles River Laboratories International by 25.9% during the 3rd quarter. Activest Wealth Management now owns 277 shares of the medical research company’s stock worth $82,000 after buying an additional 57 shares during the period. 98.91% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms recently issued reports on CRL. Zacks Research raised shares of Charles River Laboratories International from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. Evercore set a $330.00 price target on Charles River Laboratories International in a research report on Friday, September 25th. TD Cowen upped their target price on shares of Charles River Laboratories International from $300.00 to $325.00 and gave the company a “buy” rating in a research note on Friday, September 25th. Barclays increased their target price on shares of Charles River Laboratories International from $300.00 to $330.00 and gave the company an “overweight” rating in a research note on Friday, September 25th. Finally, CLSA cut Charles River Laboratories International from an “outperform” rating to a “hold” rating and set a $219.00 price target for the company. in a report on Monday, July 20th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $302.33.

Check Out Our Latest Stock Report on Charles River Laboratories International

(Get Free Report)

Charles River Laboratories International, Inc is a contract research and laboratory services company that supports pharmaceutical, biotechnology, medical device and academic research organizations. The company provides products and services used throughout the drug-development process, from early discovery and research through preclinical testing and manufacturing support.

Its offerings include research models, laboratory animal management, discovery and safety assessment services, toxicology testing, bioanalysis, and support for biologic, cell and gene therapy programs.

Read More

Five stocks we like better than Charles River Laboratories International
Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants

Receive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 14:38 1d ago
2026-10-27 08:55 1d ago
Guidewire spustil platformový přístup k agentnímu pojištění
GWRE Guidewire Software
FMP Stock News 82
Original source text
Insurers gain speed and precision across the insurance lifecycle to launch products faster, assess and price risk more effectively, and resolve claims sooner

, /PRNewswire/ -- CONNECTIONS CONFERENCE -- Guidewire (NYSE: GWRE) today launched a new platform approach to agentic insurance, giving insurers an open, secure, and complete foundation for putting AI to work across the insurance lifecycle. By bringing together the applications, data, workflows, and controls insurers need, Guidewire sets out a practical model for moving from isolated AI experiments to governed agents that improve the speed and precision of insurance decisions and actions.

"Insurance is a business of decisions and actions made in context," said Mike Rosenbaum, chief executive officer, Guidewire. "By embedding agentic capabilities where insurers already run their core operations, Guidewire gives agents the context and controls they need to work with speed and precision on a proven durable foundation."

Guidewire agents run on the same trusted platform as its core applications and work with an insurer's current data and workflows. For agents to work effectively, they need to know what is true, what has already been done, and what they are allowed to do. The platform's controls enforce those boundaries with consistent security and a clear audit trail that remains current and secure through ongoing updates.

"We took a platform approach to AI, so agents run on the same platform as the core, with access to an insurer's context, data, and workflows," said Diego Devalle, chief product development officer, Guidewire. "The scalability and observability that already support the core now support agents too. That is why insurers can put them to work on live claims and policies, and why developers can build on the same open foundation."

The examples below represent a sample of Guidewire's growing portfolio of agents and agentic capabilities across the insurance lifecycle. Guidewire will continue to expand this portfolio, giving insurers more ways to put agents to work within the workflows and controls of the Guidewire platform.

Agentic underwriting

The speed of competition in the market is putting pressure on insurers to increase product and pricing agility. Guidewire shortens the path from product concept to market, giving underwriters clearer risk context and decision support within the work they already do.

Advanced Product Designer. Product managers can now move products from intent to market-ready in days, with impact analysis, gap detection, and explainable recommendations. Agentic tooling speeds up the work of designing and refining products*.PricingCenter. Actuaries can move sophisticated pricing models to live rates in days by validating rules, factors, and adjustments while maintaining the established efficiency of promotion to production. This keeps portfolio impact visible. Native integration with PolicyCenter connects pricing decisions directly to policy workflows.*Risk Accumulation App*. Underwriters and portfolio managers can see concentration and exposure by peril on a map, from a single submission to the whole book. They can check how one risk changes portfolio exposure without leaving their normal workflow.UnderwritingCenter*. Underwriters gain greater productivity and precision and can quote directly in UnderwritingCenter. It turns raw submissions into clear risk profiles and matches risks to portfolio strategy and appetite. Direct integration moves the quote into PolicyCenter, removing the risk of handoffs.ProNavigator. Underwriters use embedded AI and Guidewire-developed agents* for submission summaries, relevant risk insights, and next-best actions.Agentic claims

Claims teams face similar pressure to act quickly while increasing the precision of each decision. Guidewire puts agentic capabilities in the flow of work, from first notice of loss through adjudication and the broader indemnity supply chain.

Concierge. Claimants connect with autonomous agents by voice or chat. The agents capture full loss details and deliver decision-ready claims to ClaimCenter.ProNavigator. Adjusters move from context to decision faster with answers, suggestions, and next-best actions from an embedded AI assistant and Guidewire-developed agents.Workers' Compensation Solution. Claims teams can help injured workers recover sooner with a connected solution that links claims work with digital tools and AI."A claim goes faster when adjusters have the facts from the start," said Amy Mollin, vice president, product management, Guidewire. "We built agents into ClaimCenter, where the work already happens, to capture the loss, summarize the file, and flag risk. That gives adjusters time back for the decisions and conversations that matter most to claimants and injured parties."

"Insurers are moving beyond AI experimentation and looking for ways to put agentic AI to work across the insurance lifecycle," said Karlyn Carnahan, executive partner, Celent. "The next challenge is making these capabilities work within the systems and workflows that run the business. That is where the platform matters. By connecting agents to core data and processes, Guidewire gives insurers a practical path to deploy them in production with the controls they need."

Agentic platform and data

Guidewire gives technical teams the infrastructure and current insurance data to put agents into production and govern how they operate.

Agentic Framework. Insurers can use Guidewire-developed agents or build their own, select the model for each task, enforce guardrails, evaluate behavior, and monitor costs.Developer Assistants. Guidewire-aware assistants help technical teams update code, workflows, and rules faster.DevSpace*. Developers start sooner in preconfigured cloud environments with built-in Guidewire tooling.Guidewire Data Platform. Policy, claims, and billing data come together in one place, so agents and predictive models draw on the same data.Data Studio and Explore. Curated P&C datasets are ready to use on day one. Insurers can also draw business insight from their own data.Kaleidoscope*. Predictive models tuned to an insurer's own book can also draw on industry and third-party data to fill gaps. Federated learning trains the models where each party's data resides, so records don't move and privacy is preserved.*"Innovation is about reimagining how work gets done and giving our people the capabilities to make that possible," said Tatjana Lalkovic, Chief Technology Officer, Definity. "Guidewire Developer Assistants bring relevant context directly into the development process, helping our teams move from idea to implementation faster while keeping human judgment and our standards at the center. It's a great example of how we're using AI to increase the pace of innovation and deliver value to our business, brokers, and customers sooner."

Guidewire is also using AI to transform how it delivers programs with customers. Across professional services, Guidewire has embedded AI into its implementation methodology, materially reducing migration and implementation timelines. This enables insurers to put new capabilities in the hands of claims and underwriting teams sooner.

Guidewire is demonstrating these advancements this week at Guidewire Connections in Las Vegas, where over 3,000 insurers and partners from 36 countries have gathered for the company's annual customer conference.

Certain release features may not be available in all regions.

*Indicates product feature is available for Early Access customers only or Guidewire Roadmap Features.

Connections keynote sessions will be livestreamed and available on-demand. To view the livestream and learn more about Guidewire's new platform approach to agentic insurance, visit the Guidewire website.

About Guidewire

Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. More than 570 insurers in 44 countries, from new ventures to the largest and most complex in the world, rely on Guidewire products. With core systems leveraging data and analytics, digital, and artificial intelligence, Guidewire defines cloud platform excellence for P&C insurers.

We are proud of our unparalleled implementation record, with 1,700+ successful projects supported by the industry's largest R&D team and consulting partner ecosystem. Our marketplace represents the largest partner community in P&C, where customers can access hundreds of applications to accelerate integration, localization, and innovation.

For more information, please visit www.guidewire.com and follow us on X and LinkedIn.

Media Contact:

Melissa Cobb
Director, Public Relations
Guidewire Software, Inc.
+1.650.464.1177
[email protected]

NOTE: For information about Guidewire trademarks, visit www.guidewire.com/legal-notices.

Cautionary Language Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the general availability of features, programs, services, and tools mentioned in this press release (including, without limitation, Advanced Product Designer, PricingCenter, Risk Accumulation App, UnderwritingCenter, ProNavigator, DevSpace, and Kaleidoscope). These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as expect, anticipate, should, believe, hope, target, project, goals, estimate, potential, predict, may, will, might, could, intend, variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Guidewire's control. Guidewire's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in Guidewire's most recent Forms 10-K and 10-Q filed with the Securities and Exchange Commission as well as other documents that may be filed by Guidewire from time to time with the Securities and Exchange Commission. In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: fluctuations in our quarterly and annual operating results; our reliance on sales to, and renewals from, a relatively small number of large customers and the related substantial negotiating leverage of these customers; the length and complexity of our sales, product development, and implementation cycles; our competitive environment and changes thereto; our ability to effectively manage international expansion; issues in the development, adoption, deployment, workforce use and maintenance of artificial intelligence ("AI") and machine learning technologies combined with an uncertain and evolving regulatory environment; long-term pricing commitments made in our customer contracts based on available information; our ability to expand adoption of our cloud-based products and services, and the risk that any of our established products may fail to satisfy customer demands or maintain market acceptance; the impact of seasonal and other variations related to our customer agreements and revenue recognition on our results of operations, ARR, and cash flows; our ability to develop, introduce, and market new and enhanced versions of our products and services; our ability to retain existing and hire new personnel, including managing a hybrid and geographically distributed workforce; errors or failures in our products or services, as well as service interruptions or failure of the third-party service providers we rely on; our dependence on the quality of our professional services and third-party global system integrator partners to sell our products and services; the impact of changes in our revenue mix, and the realization of lower gross margins from our services, subscription, and support revenues compared to our license revenue; the impact of global events (including, without limitation, macroeconomic and geopolitical conditions, ongoing global conflicts, inflation, high interest rates, and general economic volatility); data security breaches of our cloud-based services and products or unauthorized access to our employees' or our customers' data; the impact of evolving regulations and laws (including, without limitation, security, privacy, AI and machine learning, tax regulations and laws, and accounting standards); assertions by third parties that we violate their intellectual property rights; stock price volatility regardless of our operating performance; and other risks and uncertainties. Past performance is not indicative of future results. The forward-looking statements included in this press release represent Guidewire's views as of the date of this press release. Guidewire anticipates that subsequent events and developments will cause its views to change. Guidewire undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Guidewire's views as of any date subsequent to the date of this press release.

SOURCE Guidewire Software
2026-10-27 14:37 1d ago
2026-10-27 10:26 1d ago
Henry Schein čeká růst tržeb a pokles EPS
HSIC Henry Schein
FMP Stock News 85
Original source text
Key Takeaways Henry Schein's Q3 revenues are projected to rise 4% to $3.47 billion, while EPS may decline 2.9% to $1.34.
Dental merchandise strength and demand for implants may drive 4.9% distribution and 5.9% specialty growth.
Cloud-based software demand and AI adoption may support 5.3% sales growth in HSIC's technology unit.

Henry Schein, Inc. (HSIC - Free Report) is scheduled to release third-quarter 2026 results on Nov. 3, before the opening bell.

In the last reported quarter, the company posted adjusted earnings per share (EPS) of $1.27, which surpassed the Zacks Consensus Estimate by 4.10%. Henry Schein’s earnings beat estimates in each of the trailing four quarters, the average surprise being 6.46%.

Q3 Estimates for HSICThe Zacks Consensus Estimate for third-quarter revenues is pegged at $3.47 billion, which suggests an increase of 4% from the year-ago reported figure.

The Zacks Consensus Estimate for third-quarter EPS is pinned at $1.34, indicating a year-over-year decrease of 2.9%. The estimate has remained constant in the past 60 days.

Here’s a quick overview of the company’s performance leading up to this announcement.

Key Factors Likely to Have Driven HSIC’s Q3 PerformanceGlobal Distribution and Value-Added ServicesWithin this segment, U.S. dental merchandise sales have likely remained solid, led by corporate brands and exclusive products such as Curodont. Stable patient traffic and continued market share gains may have contributed to growth. Internationally, Henry Schein’s dental merchandise sales are likely to have benefited from continued strength in Canada, France, Brazil and Australia.

U.S. dental equipment sales in the previous quarter were under pressure from lower traditional equipment sales, partly offset by modest growth in digital equipment. We expect this trend to have persisted in the to-be-reported quarter as well. Equipment sales growth was especially good in Canada, Germany, Spain and the United Kingdom.

U.S. Medical Distribution sales may have benefited from growth in government-related and Home Solutions businesses, despite continued weakness in point-of-care diagnostic products. 

Our model projects Henry Schein’s Global Distribution and Value-Added Services revenues to increase 4.9% year over year in the third quarter.

Global Specialty ProductsThe segment is likely to have delivered a robust performance due to the solid demand for implants and biomaterials in both premium and value products. Implant sales in Europe might have continued to grow at a healthy pace in the third quarter, supported by demand for premium implants under the Camlog brand and value implants from Biotech Dental and Medentis. U.S. implant growth must have remained modest, partly supported by the Tapered Pro Conical implant and the recent launch of S.I.N. 360.

Endodontics sales should have continued to benefit from broad-based growth across the company's businesses.

Going by our model, Global Specialty Products’ revenues are expected to increase 5.9% year over year.

Global Technology In the third quarter, the segment might have continued to benefit from strong demand for its cloud-based software technology solutions. The ongoing integration of AI solutions into the global suite of practice management software solutions must have been a tailwind. Similar to the previous quarter, U.S. performance is expected to have been driven by the Dentrix Ascend practice management platform, while continued momentum in the Dentally cloud-based platform likely boosted international sales.

Henry Schein One’s sustained growth in cloud-based software and technology solutions should have continued in the third quarter, supported by recurring revenues and growing adoption of AI-powered tools, including its next-generation AI clinical workflow.

Our model estimates indicate Global Technology revenues will grow 5.3% year over year.

What Our Model Suggests for HSICPer our proven model, a stock with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), along with a positive Earnings ESP, has a higher chance of beating estimates. This is not the case here, as you can see below:

Earnings ESP: Henry Schein has an Earnings ESP of -0.10%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company currently carries a Zacks Rank #3. You can see the complete list of today’s Zacks Rank #1 stocks here.

Key MedTech PicksHere are some medical stocks worth considering, as these have the right combination of elements to post an earnings beat this time around:

TG Therapeutics (TGTX - Free Report) has an Earnings ESP of +71.43% and a Zacks Rank #1 at present. The company is expected to release third-quarter 2026 results soon. 

TGTX’s earnings beat estimates in one of the trailing four quarters and missed in the other three, the average surprise being 184.65%. The Zacks Consensus Estimate for third-quarter EPS implies a decrease of 84.8% from the year-ago quarter’s figure.

Revvity (RVTY - Free Report) has an Earnings ESP of +1.03% and a Zacks Rank #3 at present. The company is slated to release third-quarter 2026 results on Nov. 3.

RVTY’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6.59%. The Zacks Consensus Estimate for third-quarter EPS indicates an increase of 9.3% from the year-ago quarter’s figure.

Acadia Healthcare (ACHC - Free Report) has an Earnings ESP of +4.84% and a Zacks Rank #3 at present. The company is slated to release third-quarter results on Nov. 4.

ACHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 47.02%. The Zacks Consensus Estimate for third-quarter EPS calls for a decrease of 36.1% from the year-ago quarter’s figure.
2026-10-27 14:11 1d ago
2026-10-27 08:25 1d ago
D-Wave čelí žalobě po slabých tržbách
QBTS D-Wave Quantum
FMP Stock News 78
Original source text
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of D-Wave Quantum Inc. (NASDAQ: QBTS) securities between February 26, 2026 and August 25, 2026, inclusive (the “Class Period”), have until December 15, 2026 to seek appointment as lead plaintiff of the D-Wave class action lawsuit. Captioned Fessler v. D-Wave Quantum Inc., No. 26-cv-11953 (N.D. Cal.), the D-Wave class action lawsuit charges D-Wave as well as certain of D-Wave’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the D-Wave class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-d-wave-quantum-inc-class-action-lawsuit-qbts.html

You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].

CASE ALLEGATIONS: D-Wave engages in the development and delivery of quantum computing systems, software, and services.

The D-Wave class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants materially overstated D-Wave’s business and financial prospects; (ii) the foregoing was reasonably likely to negatively impact D-Wave’s business and reputation; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

On August 6, 2026, D-Wave announced its financial results for the second quarter of 2026, allegedly reporting revenue of just $3.08 million, compared to $3.1 million for the same period in the prior year, falling short of analyst expectations ranging from $4.03 million to $4.08 million. On this news, the price of D-Wave stock fell more than 9%, according to the complaint.

On August 25, 2026, D-Wave issued a press release “announc[ing] that John Markovich is retiring and thus resigning from his position as Chief Financial Officer effective September 2, 2026.” On this news, the price of D-Wave stock fell nearly 10%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired D-Wave securities during the Class Period to seek appointment as lead plaintiff in the D-Wave class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the D-Wave class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the D-Wave class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the D-Wave class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        Ken Dolitsky
        Michael Albert
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800/851-7783
        [email protected]
2026-10-27 14:02 1d ago
2026-10-27 08:45 1d ago
Analytici očekávají u IREN růstový potenciál 206 %
IREN IREN
FMP Stock News 72
Original source text
A neocloud panic wiped out a third of IREN's value in months, yet every analyst covering the stock refuses to issue a sell rating. The reason comes down to a set of signed contracts that tell a very different story…

The stock, IREN (NASDAQ:IREN), currently trades at $25.43, while the average analyst price target sits at $77.81. Roughly 206% of upside would follow if Wall Street is right.

IREN runs data centers and is nearly done moving from Bitcoin mining to AI cloud, leasing GPUs to hyperscalers and AI labs. Marquee deals with Microsoft (NASDAQ:MSFT | MSFT Price Prediction) and NVIDIA (NASDAQ:NVDA) include a $9.7B multi-year Microsoft AI Cloud contract and a $3.4B five-year NVIDIA AI Cloud contract plus up to $2.1B of NVIDIA investment.

The top of the target range is even more aggressive. Bernstein’s Gautam Chhugani holds a $100.00 target, and Northland’s Nehal Chokshi and Cantor Fitzgerald’s Brett Knoblauch sit at $99.00 each. Bernstein’s figure points to about 293% of upside, close to a quadruple.

A Neocloud Panic Turned a Rough Year Into a Collapse
The biggest damage came in the past month, when IREN shares fell 42.37% during a sector-wide neocloud selloff. A Gartner report predicted more than 80% of neocloud GPU-rental providers will cease operating as independent businesses by 2030, setting off a multi-session rout. Elon Musk then said more than 200 neoclouds face “guppy-level death”. Year to date, the stock is down 32.67%, a decline past the 30% mark, and it trades about 67% below its 52-week high of $76.87.

Company-specific problems added pressure. A report highlighted infrastructure and disclosure concerns, including storage failures and cooling problems, and shares fell 8.13% that session. Fiscal Q4 results also disappointed. Revenue of $137.2M missed the $140.75M consensus and fell 26.8% year over year, while a $450.4M non-cash impairment on retired mining hardware drove a $684M net loss.

Why No Analyst Rates IREN a Sell After the Crash
Contracted revenue supports the optimistic thesis. Management said $4 billion of ARR is now contracted for our 2026 capacity and $1 billion of that is operating today. Horizons 2 through 4 for Microsoft are targeted for the December quarter, with most of the revenue impact landing in the March quarter. That figure excludes $700 million of ARR from the NVIDIA contract that starts in 2027.

Pricing power forms the second factor. Recent three-year contracts priced above $20 million per megawatt of IT load, with active discussions near $25 million, and management says those deals pay back the compute in about two years. CEO Daniel Roberts put demand bluntly: “There are no idle GPUs.”

Funding is the third. IREN has about $14 billion of cash, committed GPU financing and prepayments against fiscal 2027 capex guidance of $25 billion to $30 billion. Bernstein’s thesis also leans on low-cost power and fast deployment, backed by a power pipeline exceeding 5GW.

The ratings mix stays positive:

Strong Buy: 2
Buy: 13
Hold: 5
Sell: 0

The skeptic’s point is the funding gap. IREN still targets roughly $8 billion of additional GPU financing and prepayments, and data-center financing remains unannounced.

Riot and Cipher Fell Just as Hard
A broad sector sell-off hit IREN alongside its peers.

Riot Platforms (NASDAQ:RIOT) dropped 45.26% in a month and is down 0.63% year to date. At $12.59 against a $29.84 target, it carries about 137% implied upside. Analysts are 7 Strong Buy, 14 Buy and 1 Hold, but the Street sees less upside here than at IREN.

Cipher Mining (NASDAQ:CIFR) fell 56.51% in a month and is down 47.76% year to date. At $7.71 against a $29.36 target, implied upside is about 281%, with 5 Strong Buy, 15 Buy and 2 Hold ratings.

Cipher shows the largest consensus upside in the group, which places IREN in the middle. Every one of these targets is an estimate that can be cut.

IREN Trails the S&P 500 by a Wide Margin
At $25.43, IREN sits far below the $77.81 consensus target, an implied upside of about 206% across 20 covering analysts. Those targets are one data point.

IREN is down 32.67% year to date and 59.57% over the past year. The S&P 500 is up 12.23% year to date. A beta of 4.271 explains why the moves run so wide in both directions.

A Real Backlog Priced Like a Neocloud Casualty
Optimism builds if Horizons 2 through 4 hit on schedule, ARR passes $4 billion and the data-center financing closes on reasonable terms. That path turns contracted revenue into reported revenue and gives analysts the proof they need to defend the $77.81 consensus.

Pessimism deepens if the infrastructure problems resurface, if credit markets tighten as the Gartner view gains acceptance, or if customer concentration with Microsoft and NVIDIA turns into pricing pressure. Debt-to-equity of 1.87 leaves little room for delays.

The evidence tends positive. Signed contracts with top-tier counterparties make IREN a stronger case than most neoclouds, and confirmed Horizon delivery is the key milestone for the upside case.

Contact [email protected] for any questions or corrections.
2026-10-27 13:59 1d ago
2026-10-27 08:45 1d ago
Akcie Seagate klesly navzdory 48,5% růstu tržeb ve fiskálním 4. čtvrtletí
STX.US Seagate Technology Holdings
FMP Stock News 89
Original source text
Seagate stock shed 30% in a single month even as revenue surged 48% and contracts locked in demand through 2028, leaving investors to decide whether the selloff is a warning or the setup of the year.

Seagate Technology (NASDAQ:STX | STX Price Prediction) closed at $642.14. The 24/7 Wall St. price target is $794.02, which means 23.65% upside over the next 12 months. The stock gets a buy rating with 90% confidence, which counts as high conviction.

24/7 Wall St. Price Target Summary Metric Value Current Price $642.14 24/7 Wall St. Price Target $794.02 Upside/Downside 23.65% Recommendation BUY Confidence Level 90% On the July call, CEO Dave Mosley said “data center demand now represents approximately 90% of our exabyte shipments” and that most nearline exabytes are “allocated into calendar 2028.” The selloff prices in a cycle peak that Seagate’s contracts don’t yet show.

Seagate Lost 30% in a Month Despite Record Results Shares fell 7.86% on October 22, 7.05% over the week and 30.13% over the past month. They are still up 133.96% year to date. The stock sits 43.8% below its 52-week high of $1,143.27 and about 197% above its low of $216.39. This week, Morgan Stanley (NYSE:MS) made a bullish case for battered Seagate and Western Digital (NASDAQ:WDC) shares, according to Barron’s.

Fundamentals improved: fiscal Q4 revenue reached $3.63B, up 48.5% and ahead of the $3.49B consensus. Non-GAAP EPS came in at $5.71 against a $5.09 estimate, the fourth straight beat.

Non-GAAP gross margin expanded to 52.7% from 37.9%. For fiscal Q1, management guided to revenue of $4.10B ± $100M and EPS of $7.30 ± $0.20.

Why Bulls See $1,200 Ahead HAMR technology is the growth engine. Exiting fiscal 2026, HAMR products made up about 40% of Seagate’s nearline exabyte run rate. Mozaic 4, which supports up to 44 terabytes per drive, is scaling up with the two largest cloud providers. Mozaic 5 is on track for qualification shipments in late calendar 2027.

Because each disk holds more data, profit grows without adding factory output. Management said incremental gross margin is “well above the 60% figure.” Agentic AI could add more demand as KV cache data spills onto hard drives, and so could physical AI, though Mosley called both “very early days.”

Wall Street mostly agrees: 4 Strong Buys, 18 Buys, 2 Holds and 1 Strong Sell. The bull case hits $1,201.97, an 87.18% gain.

Risks That Could Stall the Storage Upcycle Hard drives have a long history of boom-and-bust cycles, and Seagate depends heavily on a small group of hyperscalers whose capex plans drive the whole order book (we profiled seven of the non-chip suppliers riding that same expansion, from power to cooling to storage, in a free report).

Other risks include dilution from the Exchangeable Senior Notes due 2028, tariffs, exposure to the Middle East conflict and settlement payments to the Commerce Department’s BIS. Still, contracts set product configuration and pricing for all of calendar 2027, and Seagate paid down $1.40B of debt. The bear case sits at $614.24, a decline of just 4.34%.

Seagate Trades Below Western Digital’s Multiple Western Digital is the other half of the HDD duopoly. In fiscal Q1, its revenue grew 55.46% and non-GAAP gross margin hits 58.1%. It trades near 23x forward earnings, compared with our about 18x for Seagate.

Micron Technology (NASDAQ:MU) gives a memory-side contrast. At about 7x forward earnings, it shows how cheaply the market prices AI hardware it views as cyclical.

Company Forward P/E TTM Operating Margin Seagate 18x 43.1% Western Digital 23x 43.6% Micron 7x 80.7% Seagate’s margins are almost the same as Western Digital’s, yet it trades at a lower multiple. That makes the 24/7 Wall St. price target look reasonable, and arguably conservative.

Contracted Demand Supports a BUY The 24/7 Wall St. price target of $794.02 carries a buy rating and 90% confidence. The critical factor is supply that is already allocated into 2028.

The thesis improved if fiscal Q1 results land near guidance and Mozaic 4 hits its milestones. It weakens if hyperscalers start shortening their planning horizons. Those are the signals to watch from here.

Year 24/7 Wall St. Price Target 2026 $794.02 2027 $910.18 2028 $1,050.87 2029 $1,139.69 2030 $1,207.07 The outlook depends on Seagate keeping its HAMR roadmap on track. A sharp cut in hyperscaler capex is the biggest downside risk, while demand from agentic and physical AI is the biggest source of upside.

Contact [email protected] for any questions or corrections.
2026-10-27 13:55 1d ago
2026-10-27 08:00 1d ago
nVent otevře v Arizoně výrobní závod s 200 pracovními místy
NVT nVent Electric
FMP Stock News 88
Original source text
400,000-square-foot site will support growing customer demand in the infrastructure vertical, including data centers and power utilities

Production anticipated to begin mid-2027, adding at least 200 new manufacturing jobs in the Phoenix metro area

LONDON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- nVent Electric plc (NYSE:NVT), a global leader in electrical connection and protection solutions, today announced the lease of new manufacturing space in Goodyear, Ariz. The 400,000 square-foot site will expand nVent's capacity to manufacture engineered buildings, including prefabricated electrical houses (e-houses), that help customers accelerate the deployment of critical power infrastructure for power utility, data center, industrial and other infrastructure applications. This new site is expected to begin production in mid-2027 and will employ more than 200 people once fully operational.

"Demand for our engineered building products continues to grow as customers invest in grid modernization, power reliability and other critical infrastructure projects," said Sara Zawoyski, President, nVent Systems Protection. "This new facility expands our ability to serve customers with the speed, scale and technical expertise needed to support increasingly complex projects that require faster deployment and execution."

This is the latest expansion to support growth in demand for nVent engineered building products this year. In August, the company broke ground on a 58,000-square-foot expansion at an existing facility in Southeastern Kansas, expected to create up to 60 new skilled trade positions over the next year.

About nVent
nVent is a leading global provider of electrical connection and protection solutions. We believe our inventive electrical solutions enable safer systems and ensure a more secure world. We design, manufacture, market, install and service high-performance products and solutions that connect and protect some of the world’s most sensitive equipment, buildings and critical processes. We offer a comprehensive range of systems protection and electrical connections solutions across industry-leading brands that are recognized globally for quality, reliability and innovation. Our principal office is in London and our management office in the United States is in Minneapolis.

Our robust portfolio of leading electrical product brands dates back more than 100 years and includes nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE. Learn more at www.nVent.com.

This press release contains statements that we believe to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact are forward looking statements. Without limitation, any statements preceded or followed by or that include the words “targets,” “plans,” “believes,” “expects,” “intends,” “will,” “likely,” “may,” “anticipates,” “estimates,” “projects,” “forecasts,” “should,” “would,” “could,” “positioned,” “strategy,” “future,” “are confident,” or words, phrases or terms of similar substance or the negative thereof, are forward-looking statements. All projections in this press release are also forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Among these factors are adverse effects on our business operations or financial results, including the overall global economic and business conditions impacting our business; the ability to achieve the benefits of our restructuring plans; the ability to successfully identify, finance, complete and integrate acquisitions, including the Maverick Power acquisition; competition and pricing pressures in the markets we serve; the impacts of tariffs; volatility in currency exchange rates, interest rates and commodity prices; inability to generate savings from excellence in operations initiatives consisting of lean enterprise, supply management and cash flow practices; inability to mitigate material and other cost inflation; risks related to the availability of, and cost inflation in, supply chain inputs, including labor, raw materials, commodities, packaging and transportation; increased risks associated with operating foreign businesses; risks associated with or arising from military conflicts; the ability to deliver backlog and win future project work; failure of markets to accept new product introductions and enhancements; the impact of changes in laws and regulations, including those that limit U.S. tax benefits; the outcome of litigation and governmental proceedings; and the ability to achieve our long-term strategic operating goals. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. All forward-looking statements speak only as of the date of this press release. nVent assumes no obligation, and disclaims any obligation, to update the information contained in this press release.

Investor Contact
Tony Riter
Vice President, Investor Relations
nVent
763.204.7750
[email protected]

Media Contact
Kevin H. King
Vice President, Global Communications
nVent
763.291.0526
[email protected]
2026-10-27 13:50 1d ago
2026-10-27 09:00 1d ago
Apple zvýšil tržby o 16,4 % a překonal odhady zisku na akcii
AAPL Apple
FMP Stock News 85
Original source text
Apple just logged its ninth straight earnings beat while Siri AI sits at the center of a battle between surging services growth and mounting memory costs that could push the stock in opposite directions.

The 24/7 Wall St. price target for Apple (NASDAQ:AAPL | AAPL Price Prediction) is $398.25 over the next 12 months. That means 15.77% upside from the $343.99 October 21 close. Shares traded at $345.36 late this morning. Our rating is buy, and the model’s confidence is high.

Metric
Value

Current Price
$345.36

Price Target from 24/7 Wall St.
$398.25

Upside/Downside
15.77%

Recommendation
BUY

Confidence Level
90%

Our high confidence comes from how broad Apple’s growth has become. iPhone, Mac and Services all grew by double digits last quarter. The new Siri AI also gives Apple’s installed base of more than 2.5 billion active devices a reason to upgrade their hardware and pay for more services.

Nine Straight Beats Keep Apple Near Its 52-Week High
Apple is up 27.39% year to date and 31.92% over the past year. It has gained 1.88% over the past month. Shares sit about 6% below the 52-week high of $348.15 and well above the low of $242.76.

For fiscal Q3, Apple reported revenue of $109.42 billion (+16.4% YoY). EPS came in at $2.02 against a $1.89 estimate, the company’s 9th straight EPS beat. This week, Bloomberg called Apple investors’ favorite AI hedge because of its cash flow.

CNBC reported that the iPhone Duo is in short supply. The July call was also Tim Cook’s last, and John Ternus was named to lead future calls.

Why Bulls See Siri AI Pushing Apple Past $450
Cook described Siri AI as “a completely reimagined version of Siri that is profoundly capable, deeply personal, and integrated seamlessly across our platforms.” Apple can also make money from it through iCloud+ upgrades, where users “can buy up the stack.”

Services already brought in $30.7 billion (+12%), with more than one and a half billion paid subscriptions. Mac revenue rose 29% as customers use it for on-device AI work. A new $100 billion buyback and a dividend raised to $0.27 also support the stock.

Among analysts, 6 rate it Strong Buy and 19 rate it Buy. The bull case hits $452.19, a 31.46% gain.

Memory Costs and Supply Limits Could Stall the Rally
Cook called memory pricing “a 100-year flood,” and Apple has reluctantly raised prices. Guidance calls for a September-quarter gross margin of 47%-48%, which includes one-time tariff refunds.

Last quarter, those refunds added 2pp to margin and $0.11 to EPS. Siri AI’s launch in the EU and China still needs regulatory work, and 6 analysts rate the stock Sell or Strong Sell.

Operating expenses rose 23% because of R&D spending that funds AI. Cook also said the supply crunch is “a demand forecast issue.” The bear case hits $337.78, a modest 1.8% decline.

Is Apple Pricier Than Microsoft and Alphabet?

Company
P/E
FCF Yield
Net Margin

Apple
45x
1.97%
26.9%

Microsoft
30x
1.69%
40.3%

Alphabet
15x
1.76%
32.8%

The closest megacap AI platform to compare with Apple is Microsoft (NASDAQ:MSFT). Its Azure business grew 43%, but Q4 free cash flow fell 23.19% as capex rose 109.63%.

Direct competition with Apple comes from Alphabet (NASDAQ:GOOGL) through Android and Gemini. Its low P/E is inflated by a $99.03 billion gain on equity securities. Alphabet’s Q2 free cash flow was negative $5.855 billion, and it suspended buybacks.

Apple has the highest multiple of the three. It is also the only one funding AI without giving up shareholder returns. Next to these peers, the 24/7 Wall St. price target looks reasonable.

Bottom Line: Siri AI Tips the Scale Toward Upside
The 24/7 Wall St. price target remains at $398.25, with a buy rating and high confidence. The key driver is earnings growth that is still outpacing Apple’s multiple.

The outlook improves if Siri AI drives more iPhone upgrades and iCloud+ sign-ups. The outlook weakens if memory costs push gross margin below guidance. On balance, our model points to further upside for Apple.

Looking further out, here is where the model projects Apple trading if current growth trends hold.

Year
Price Target from 24/7 Wall St.

2026 (Dec.)
$349.65

2027 (Oct.)
$397.25

2028 (Oct.)
$443.95

2029 (Oct.)
$491.53

2030 (Oct.)
$523.62

The projections rest on Apple continuing to execute on its current strategy. By 2030, a strong Siri AI launch could lift the stock toward $625.31, while persistent margin pressure points closer to $367.52.

Contact [email protected] for any questions or corrections.
2026-10-27 13:50 1d ago
2026-10-27 06:40 1d ago
Meta provede štěpení akcií v poměru 2:1 kvůli Zuckerbergově kontrole
FB Meta Platforms
FMP Stock News 94
Original source text
Stock splits are a form of financial engineering that companies can use to alter their stock prices for a whole host of reasons. They essentially allow companies to simultaneously change their stock price and share count outstanding without moving the market cap.

Companies may conduct traditional stock splits if their stock price has risen significantly and they want to make it feel more affordable, particularly for retail investors. This also increases the number of shares outstanding and, therefore, liquidity.

The opposite of a traditional stock split is a reverse stock split, which can raise a company's stock price if it has fallen out of minimum price compliance on a major exchange.

Wall Street just learned about its next major stock split, scheduled for 2027. It's being done by a major artificial intelligence (AI) company whose stock has surged 1,615% during the past 14 years since its initial public offering (IPO).

Image source: Getty Images.

Maintaining control of voting power During its third-quarter earnings report, the "Magnificent Seven" AI hyperscaler Meta Platforms (META -0.83%) said that it plans to conduct a 2-for-1 stock split on Jan. 19, 2027.

In a traditional 2-for-1 stock split, shareholders will see their share count double. The stock price will then be cut in half, so the market cap remains unchanged.

Meta plans to create a newly established Class C non-voting common stock, so every Class A and super-voting Class B shareholder will receive one share of the newly created Class C stock.

One reason for the move, according to Meta's earnings report, is to ensure that co-founder and Chief Executive Officer Mark Zuckerberg maintains his voting control, which is more than 60% of the voting shares, mainly through his ownership of super-voting Class B shares, according to a recent securities filing.

"The Special Committee concluded that Mr. Zuckerberg is best suited to lead Meta into its next era and beyond. They recognized that Meta's track record of significant value creation for its shareholders is in large part due to his strong leadership, unique and creative vision, and exceptional management abilities," Meta stated in its earnings report. "The creation of the Class C common stock will continue the founder-led model that has driven the company's success since its inception."

META Meta Platforms$625.33-$5.23 (-0.83%)

NASDAQ · As of 9:32 AM ET 10/27/26

The creation of the shares also comes as California voters will soon head to the polls to vote on Proposition 40, a proposal that would levy a one-time 5% wealth tax on California residents with a net worth of more than $1 billion.

The securities filing also noted that Zuckerberg has only taken a $1 annual salary since 2013. If Zuckerberg had to sell some of his class B stock to cover the tax liability, it could be large enough to lower his voting control to roughly 53%, the filing stated.

The filing also states Zuckerberg will be able to sell 20% of the Class C shares he receives "without restriction."

The split could be foreshadowing another large equity raise In its earnings report, Meta also said the new Class C common stock could help fund its growth, particularly as it continues to make huge AI capital expenditures (capex), primarily to build data centers.

Once the Class C shares are created, Meta could issue new shares to raise funding without diluting Zuckerberg's voting power.

Meta already plans to spend $135 billion to $145 billion on AI capex this year and just reported negative free cash flow in the third quarter. Furthermore, the company continues to believe it will need to raise hundreds of billions of dollars more to continue supporting its AI build-out.

JPMorgan Chase analyst Doug Anmuth recently wrote in a research note that Meta should raise capital "sooner" than later to remove an "overhang" on the stock right now, according to Barron's.

Ultimately, everything Meta is doing shows how a stock split can be used to advance a corporate agenda.
2026-10-27 13:50 1d ago
2026-10-27 08:00 1d ago
Uber Eats nabídne rozvoz z více než 300 prodejen Key Food
UBER Uber
FMP Stock News 85
Original source text
-

Over 300 independently owned Key Food locations across the Northeast and Florida join the Uber Eats marketplace, bringing fresh groceries and everyday essentials to customers on-demand

SAN FRANCISCO--(BUSINESS WIRE)--Uber Technologies, Inc. (NYSE: UBER) and Key Food Stores Co-Operative, Inc., a prominent chain of family-owned and -operated supermarkets, today announced a partnership that brings grocery delivery from more than 300 Key Food member stores across the Northeast and Florida to Uber Eats, giving customers more ways to shop their local supermarkets. The partnership builds on Uber Eats' continued investment in grocery and retail, as the company grows its footprint with national and regional supermarket brands across the country.

Customers can shop from participating stores in Key Food’s Family of Supermarkets, including Key Food, Food Universe, SuperFresh, The Food Emporium, Food Dynasty, and more, directly through the Uber Eats app. Customers can access a wide selection of fresh produce, meat, seafood, pantry staples, household essentials and more, with on-demand and scheduled delivery options.

“Key Food’s stores understand the neighborhoods they serve, and bringing these retailers to Uber Eats gives customers greater access to the local grocery selection they know and rely on,” said Prashant Garg, Head of North America, Uber Eats. “Whether they’re scheduling a grocery order on the way home from work or need an ingredient they forgot at the store, this gives shoppers more choice in where they shop for groceries, and more flexibility in how they get them.”

Founded in Brooklyn in 1937, Key Food is a Co-Operative of Supermarkets serving communities throughout the Northeast and Florida. Each member independently owns and operates its stores, enabling retailers to tailor their assortments and service to the needs of their local customers.

“Our members are the foundation of the Co-Op, with deep roots in their communities and lasting relationships with the customers they serve,” said Dean Janeway, CEO of Key Food Stores Co-Operative, Inc. “Our partnership with Uber Eats is a strategic step in evolving how we serve our customers, expanding our digital footprint, supporting our members’ growth, and making it more convenient for shoppers to access their neighborhood Key Food stores.”

How it Works

Shopping your local participating store in the Key Food Family of Supermarkets through Uber Eats is simple:

Open the Uber Eats app and tap “Grocery.”Select an available participating store and browse a wide assortment of groceries and household items.Add items to your cart, choose your delivery time and place your order.Track your delivery in real time.The partnership is open to eligible Key Food Co-Op stores interested in joining the Uber Eats marketplace. As the rollout continues, member stores can opt in to bring on-demand delivery to their customers through Uber Eats.

About Uber

Uber’s mission is to create opportunity through movement. We started in 2010 to solve a simple problem: how do you get access to a ride at the touch of a button? More than 79 billion trips later, we're building products to get people closer to where they want to be. By changing how people, food, and things move through cities, Uber is a platform that opens up the world to new possibilities.

About Key Food Stores Co-Operative, Inc.

Founded in Brooklyn in 1937, Key Food Stores Co-Operative, Inc. includes over 480 family-owned and operated supermarkets with $5.7 billion in annual sales. In addition to Key Food, these stores operate under various other banners including; Food Universe, The Food Emporium, and SuperFresh in all five boroughs of NYC, Long Island New York, upstate New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Rhode Island, Maryland and Florida. Please visit www.keyfood.com for more information.

More News From Uber Technologies, Inc.

Back to Newsroom
2026-10-27 13:50 1d ago
2026-10-27 09:30 1d ago
Tržby Google Cloud vzrostly o 82 %
GOOGL Alphabet
FMP Stock News 82
Original source text
Alphabet just posted its biggest Cloud growth quarter yet while the stock sits more than 20% below its highs, but the bear case risks are real enough to give even bulls pause. Here is what our model found when it…

Alphabet (NASDAQ:GOOG | GOOG Price Prediction) closed at $320.76. The 24/7 Wall St. price target stands at $423.95, meaning 32.17% upside over the next 12 months. The stock gets a buy rating from our model, with fairly high confidence.

24/7 Wall St. Price Target Summary Metric Value Current Price $320.76 Price Target from 24/7 Wall St. $423.95 Upside/Downside 32.17% Recommendation BUY Confidence Level 70% The market is focused on the cost of Alphabet’s AI buildout. More weight goes to what that spending is already producing: a Cloud business that grew 82% last quarter and a backlog of $514 billion.

A Sharp October Pullback Follows a Record Quarter GOOG fell 7% over the past week and 7.67% over the past month, including a 3.08% drop on October 22. Shares are still up 2.42% year to date and 27.35% over 12 months. The stock trades roughly 21% below its 52-week high of $403.96 and about 26% above its low of $255.43.

In Q2, revenue reached $119.80 billion (up 24.23%), beating the $116.91 billion estimate. EPS came in at $9.11 against a $3.04 estimate.

A $99.03 billion unrealized gain on equity securities accounts for much of that EPS beat. Investors are looking for fresh reasons to own the stock: Forbes this week asked what makes Google stock a buy.

Why Bulls See $442 and Beyond Cloud is the engine. Growth went from 34% to 48% to 63% to 82% across four quarters, and Cloud operating margin rose to 35.6% from 20.7%. AI Mode has passed 1 billion monthly active users and the Gemini app has 950 million. Management expects most TPU system sales revenue to arrive in 2027.

Sundar Pichai called it “extraordinary opportunities with extraordinary returns.” Wall Street agrees, with 13 Strong Buy, 44 Buy, and 5 Hold ratings and zero Sells. The bull case stands at $442.71.

What Could Derail the AI Payoff Q2 capex hit $44.92 billion and drove free cash flow to -$5.86 billion. Long-term debt rose from $46.5 billion to $98.2 billion, buybacks are on hold, and a $49.6 billion equity raise dilutes existing holders. EU regulatory risk also remains.

On the other side, trailing 12-month free cash flow was still $53.3 billion and interest coverage is 175.5x. The bear case of $365.73 is still above today’s price.

Alphabet Trades at a Discount to Microsoft and Meta Company P/E P/FCF Operating Margin Alphabet 13 55 32.06% Microsoft (NASDAQ:MSFT) 29 58 46.78% Meta Platforms (NASDAQ:META) 24 31 41.44% Microsoft competes directly with Alphabet in cloud. Azure grew 43%, well behind Google Cloud’s pace, yet Microsoft trades at more than twice Alphabet’s P/E.

Meta Platforms competes for digital ad budgets and is spending just as heavily on AI. Meta’s Q3 operating margin fell to 20% from 40%. Our target meaning about 16x trailing earnings, which still sits below both peers. That makes it look conservative, even after allowing for Alphabet’s one-time equity gains.

What Could Tip Alphabet’s Outlook From Here The 24/7 Wall St. price target is $423.95, rated buy with 70% confidence. Cloud’s accelerating, increasingly profitable growth is what drives our model’s call.

A stronger bull case appears if the backlog keeps turning into revenue at expanding margins. Downside risk grows if free cash flow remains negative while borrowing keeps rising. For now, our model’s upside scenario outweighs its downside scenario.

Alphabet Price Prediction 2026-2030 Year Price Target from 24/7 Wall St. 2026 $423.95 2027 $482.32 2028 $548.72 2029 $624.26 2030 $710.20 Alphabet needs to keep executing its full-stack AI strategy for these projections to hold. Gemini 4’s competitiveness or a slowdown in Cloud demand could move results sharply in either direction.

Contact [email protected] for any questions or corrections.
2026-10-27 13:50 1d ago
2026-10-27 07:15 1d ago
Amazon plánuje v roce 2026 kapitálové výdaje ve výši 220 mld. USD
AMZN Amazon
FMP Stock News 90
Original source text
Amazon's stock has barely budged this year, yet the business underneath it is accelerating in ways that make most rivals look structurally overpriced. One looming risk, though, could unravel the entire thesis if a single market condition shifts.

I added to my Amazon (NASDAQ:AMZN | AMZN Price Prediction) position again. Every earnings report gives me another reason to keep doing it. The stock sits at $249.09, up only 7.92% year to date, while the business behind it speeds up. That gap is why I keep adding.

Three Moats Protecting Amazon’s Margins
My thesis is simple. Amazon controls its own costs in AI. The company designs its own chips, offers every major AI model through one platform, and uses robots to move physical goods at a scale I have not seen any retailer match.

Start with custom silicon. Amazon’s chips business runs at an annual revenue rate of over $25 billion, growing at triple-digit rates. Graviton is used by 98% of Amazon’s top 1,000 EC2 customers, and Anthropic and OpenAI both signed multi-year Trainium commitments measured in gigawatts. Cheaper in-house chips helped AWS post a 39% operating margin on $42.2 billion in revenue, which grew 36.7%. That was its fastest growth in 18 quarters.

Second, Bedrock works with any model. It added 10+ foundation models, including OpenAI GPT and Anthropic Claude, and customers spent more on it in Q2 than in all prior quarters combined. CEO Andy Jassy put it simply: “There is not going to be one model to rule the world.” Amazon gets paid whichever model customers pick. An AWS backlog of $496 billion tells me enterprises agree.

Third, automated logistics. Amazon delivered over 40% more items same day or overnight in the first half of the year, plans to more than double its robotic-arm fleet in 2026 and launched a next-generation Proteus robot. Operating income rose 43.24% to $27.46 billion while revenue grew 19.62%. Profits growing faster than sales is exactly what I want to own.

Why My Money Skips Walmart and Microsoft
Walmart (NASDAQ:WMT) trades at a P/E of 44, compared with Amazon’s 35. Walmart’s operating margin is 4.18% and Amazon’s is 11.16%, and Walmart’s revenue grew 5.94% last quarter. I see no reason to pay more for slower growth and lower margins with no cloud business attached.

The stronger rival is Microsoft (NASDAQ:MSFT), with Azure growing 43%. Still, Microsoft trades at 8.94 times book value, while Amazon trades at 6.54. Its More Personal Computing segment also contracted 4%. Every Amazon business line grew, from advertising at 26% to physical stores at 4%.

Free Cash Flow Is the Risk I Watch Most
Amazon now expects about $220 billion in 2026 capital spending, up from about $200 billion, because memory costs rose. Free cash flow for the past 12 months turned negative, at -$7.6 billion. Q2 GAAP EPS of $5.75 also included a $53.4 billion one-time gain on Amazon’s Anthropic stake, recorded before taxes. If AI demand cools, that spending leaves Amazon with idle capacity.

I still hold my thesis because Amazon builds against demand customers have already signed for. Jassy said most capacity coming online in 2027 is already reserved, most AI capacity sits under contracts of at least five years, and servers pay for themselves in a little under three years. All that spending has to be powered, cooled and connected by somebody, and we rounded up seven suppliers riding the same expansion in a free AI infrastructure report. Debt-to-equity of 0.37 leaves room to fund the expansion.

What Keeps My Buy Button Active
Q3 guidance calls for operating income of $22.5 billion to $26.5 billion, up from $17.4 billion a year earlier. Jassy now believes AWS could become “a trillion-dollar annual revenue business for us in time.” Amazon builds the chips, hosts the models and delivers the boxes, and I plan to keep buying more of all three.

Contact [email protected] for any questions or corrections.
2026-10-27 13:48 1d ago
2026-10-27 09:20 1d ago
AMD investuje 1 miliardu USD do akcií společnosti Meta
AMD AMD
FMP Stock News 92
Original source text
News Highlights

AMD and Meta collaborate across CPUs, GPUs, networking, systems and software to power Meta services and AI infrastructureAMD Helios rackscale solutions will power Meta’s leading frontier models and servicesAMD technology is the compute engine of choice for Muse and AMD technologies provide Day-0 support for leading Meta models SANTA CLARA, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today highlighted its deep strategic partnership with Meta, announcing AMD Helios™ rackscale solutions are running at Meta, AMD EPYC™ processors power Meta’s Muse AI agent, and AMD technologies provide Day-0 support for Meta models including Muse Spark Open and Muse Glimmer.

This builds on years of co-design and collaboration between the two companies across AMD EPYC™ processors, AMD Instinct™ GPUs, AMD Pensando™ networking and AMD ROCm™ AI infrastructure.

“Meta is a strategic partner for AMD, and we have built this partnership through years of deep technical collaboration – from EPYC processors powering Meta’s infrastructure to Instinct GPUs and open software supporting its AI workloads,” said Lisa Su, Chair and CEO, AMD. “With Helios now running at Meta, we are taking that partnership to a new scale in the superintelligence era. Together, we are building and deploying infrastructure at gigawatt scale and shaping future generations of silicon, software and systems to enable Meta’s most ambitious superintelligence models and services.”

“AMD has been a key partner in building out the compute that's running our frontier models,” said Mark Zuckerberg, founder and CEO, Meta, “We're making big investments in the computing power that will enable us to bring personal superintelligence to everyone, and AMD plays an important role in that.”

AMD Powering Meta Infrastructure, Today
AMD technology powers Meta’s infrastructure across compute, networking, systems and software.

Initial AMD Helios rackscale solutions are installed and being tested by Meta on the path to a broader deployment in the near future.AMD EPYC processors support the dedicated computing environments behind Meta’s Muse personal AI agent. Meta has deployed millions of EPYC processors across multiple generations and is a lead customer for 6th Gen EPYC™ CPUs. The companies are also collaborating on future generations, including “Verano.”AMD Instinct GPUs are currently used in production in Meta’s infrastructure for training, ranking and recommendation engines. Meta was also an early definition customer for the AMD Instinct™ MI450 architecture, and it will deploy a custom AMD Instinct GPU that is optimized for its workloads. The collaboration is also informing future AMD platforms, including AMD Instinct™ MI500 series GPUs and next-generation rack-scale systems.AMD and Meta have worked together to advance ROCm through PyTorch to ensure that developers can leverage AMD GPUs right out of the box. As well, AMD delivered Day-0 support for Meta's Muse Spark Open models on AMD Instinct GPUs and for Muse Glimmer on AMD Ryzen™ AI PCs and AMD Radeon™ GPUs.AMD and Meta have expanded their software collaboration to large-scale AI training, optimizing recommendation models on AMD Instinct MI350X GPUs and contributing improvements to PyTorch, Triton and ROCm for other developers to use. As Meta grows its AI capabilities, the companies are working together across silicon, software and systems to address the demands of operating AI infrastructure for billions of people. The companies have aligned product roadmaps and engineering decisions around current and future Meta workloads, evolving years of collaboration into building and deploying integrated AI systems at gigawatt scale.

In addition, AMD will invest $1 billion in Meta’s equity offering.

Supporting Resources

Learn more about AMD Instinct GPUsLearn more about AMD EPYC CPUsLearn more about AMD HeliosFollow AMD on LinkedInFollow AMD on X  About AMD
AMD (NASDAQ: AMD) drives innovation in high-performance and AI computing to solve the world’s most important challenges. Today, AMD technology powers billions of experiences across cloud and AI infrastructure, embedded systems, AI PCs and gaming. With a broad portfolio of AI-optimized CPUs, GPUs, networking and software, AMD delivers full-stack AI solutions that provide the performance and scalability needed for a new era of intelligent computing. Learn more at www.amd.com.

Cautionary Statement
This press release contains forward-looking statements concerning Advanced Micro Devices, Inc. (AMD) such as the collaboration, expectations and anticipated benefits of the strategic partnership with Meta including the expected broader deployment of AMD Helios rack-scale systems in the near future; the companies collaborating on future generations of AMD EPYC™ processors including “Verano”; the collaboration informing future AMD platforms including AMD Instinct MI500™ series GPUs and next-generation rack-scale systems; and the companies aligning product roadmaps and engineering decisions around current and future Meta workloads, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "expects," "believes," "plans," "intends," "projects" and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this press release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and are generally beyond AMD's control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors that could cause actual results to differ materially from current expectations include, without limitation, the following: impact of government actions and regulations such as export regulations, national-security-based regulations, import tariffs, trade protection measures, and licensing requirements; competitive markets in which AMD’s products are sold; the cyclical nature of the semiconductor industry; market conditions of the industries in which AMD products are sold; AMD’s ability to introduce products on a timely basis with expected features and performance levels; loss of a significant customer; economic and market uncertainty; quarterly and seasonal sales patterns; AMD's ability to adequately protect its technology or other intellectual property; unfavorable currency exchange rate fluctuations; ability of third party manufacturers to manufacture AMD's products on a timely basis in sufficient quantities and using competitive technologies; availability of essential equipment, materials, components (such as memory supply), substrates or manufacturing processes; ability to achieve expected manufacturing yields for AMD’s products; AMD's ability to generate revenue from its semi-custom SoC products; potential security vulnerabilities; potential security incidents including IT outages, data loss, data breaches and cyberattacks; uncertainties involving the ordering and shipment of AMD’s products; AMD’s reliance on third-party intellectual property to design and introduce new products; AMD's reliance on third-party companies for design, manufacture and supply of motherboards, software, memory and other computer platform components; AMD's reliance on Microsoft and other software vendors' support to design and develop software to run on AMD’s products; AMD’s reliance on third-party distributors and add-in-board partners; impact of modification or interruption of AMD’s internal business processes and information systems; compatibility of AMD’s products with some or all industry-standard software and hardware; costs related to defective products; failure to maintain an efficient supply chain as customer demand changes; AMD's ability to rely on third party supply-chain logistics functions; AMD’s ability to effectively control sales of its products on the gray market; impact of climate change on AMD’s business; AMD’s ability to realize its deferred tax assets; potential tax liabilities; current and future claims and litigation; impact of environmental laws, conflict minerals related provisions and other laws or regulations; evolving expectations from governments, investors, customers and other stakeholders regarding corporate responsibility matters; issues related to the responsible use of AI; restrictions imposed by agreements governing AMD’s notes, the guarantees of Xilinx’s notes and the revolving credit agreement; AMD’s ability to satisfy financial obligations under guarantees, leases and other commercial commitments; impact of acquisitions, joint ventures and/or investments on AMD’s business and AMD’s ability to integrate acquired businesses; impact of any impairment of the combined company’s assets; political, legal and economic risks and natural disasters; future impairments of technology license purchases; AMD’s ability to attract and retain key employees; and AMD’s stock price volatility. Investors are urged to review in detail the risks and uncertainties in AMD’s Securities and Exchange Commission filings, including but not limited to AMD’s most recent reports on Forms 10-K and 10-Q.

AMD, the AMD Arrow logo, AMD Instinct, AMD Pensando, AMD ROCm, EPYC and combinations thereof are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.
2026-10-27 13:47 1d ago
2026-10-27 08:46 1d ago
Tilray Brands vykázala provozní ztrátu 60,5 milionu USD
TLRY Tilray
FMP Stock News 85
Original source text
How much lower can Tilray Brands (TLRY -3.20%) stock go? In the past five years, it has lost a whopping 97% of its value, and since the start of 2026, it's already down around 70%. Although the business has grown and diversified its operations, investors haven't seen a payoff from its efforts, as Tilray continues to struggle with overall profitability.

Has its decline been so significant that now can be a good time to buy the stock, despite its risks? Here's what investors need to know.

Image source: Getty Images.

Tilray's been growing via acquisitions, but its fundamentals remain underwhelmingAt its core, Tilray is a Canadian-based cannabis company. Like many of its peers, it's been eagerly waiting for and hoping for the day the U.S. market opens up, so that it can enter it and generate much more revenue from that area of its operations.

Legalization, however, isn't on the horizon. In the meantime, competition is fierce, and growth opportunities are limited in Canada. Some cannabis producers have gotten leaner to trim costs, but Tilray has gone the route of expansion via acquisitions, loading up on beverage and alcohol brands. By doing so, its business has become larger, and it's expanded its presence in the U.S., potentially putting itself in a stronger position if and when marijuana legalization takes place.

But the businesses and brands it has been acquiring aren't exactly all that strong. And over the trailing 12 months, Tilray has generated more than $963 million in revenue but has still incurred an operating loss of $60.5 million.

There hasn't been much consistent growth; organically, the business is struggling, and instead, acquisitions and entering new markets have been the main drivers. It's also difficult to see a path to profitability, particularly given that acquisitions remain a key part of Tilray's growth strategy.

TLRY Tilray Brands$2.72-$0.09 (-3.20%)

NASDAQ · As of 4:00 PM ET 10/26/26

Investors shouldn't assume Tilray's stock can't go lowerTilray's stock may look cheap, with a valuation of around $400 million and annual sales approaching $1 billion, but that doesn't mean it's a good buy or that it's overdue for a rally. It's still unprofitable, its growth prospects aren't all that great, and it's still burning through cash from its day-to-day operations.

I would prefer to see the business get leaner, rather than more bloated with acquisitions. I understand the strategy -- to simply have more growth opportunities, but that doesn't make Tilray a better overall investment. With continual losses and cash burn, there just isn't a compelling reason to take a chance on the stock, as it can still go lower.
2026-10-27 13:46 1d ago
2026-10-27 08:10 1d ago
Investice technologických gigantů podpoří poptávku po GPU společnosti Nvidia
NVDA Nvidia
FMP Stock News 92
Original source text
Investors have focused heavily on technology giants in recent years as these companies are driving the artificial intelligence (AI) revolution. They are the ones spending on the infrastructure build-out, or developing and providing the products and services needed to advance the AI story.

And as a result, this week, with big tech set to report earnings, should be a big one for investors. Microsoft (MSFT +1.54%) and Alphabet (GOOG -0.97%) (GOOGL -1.06%) kick things off with quarterly updates on Oct. 28 after the closing bell, and Amazon's (AMZN +0.44%) report is scheduled for Oct. 29 after the close of trading.

These reports should be important for the entire market, considering that AI has set the tone for the overall direction of the S&P 500. Tech giants are heavily weighted in the index and therefore guide its ups and downs. But investors in one particular company should be keenly interested in this week’s reports: I'm talking about Nvidia (NVDA +2.39%) investors. In fact, they should watch one crucial number. Let's zoom in for a close look.

Image source: Getty Images.

Nvidia's role in AIIt's important to first consider Nvidia's role in the AI boom. This technology company makes graphics processing units (GPUs), chips that were originally known for their use in the video gaming market. And the gaming customer was once Nvidia's biggest. Then, about a decade ago, Nvidia recognized the AI opportunity and focused the design of GPUs to suit the needs of this industry.

Fast forward to the start of the AI stock market boom, about three years ago, and it was clear that Nvidia had won its AI bet. The company's earnings have been soaring in the double and triple digits, quarter after quarter, to record levels. This is as customers knock at the door, eager to get in on Nvidia's GPUs. The company faces rivals in the space, but so far, it has remained ahead thanks to the speed of its GPUs and its vast selection of related offerings.

NVDA Nvidia$216.00+$5.04 (+2.39%)

NASDAQ · As of 4:00 PM ET 10/26/26

In the latest quarter, Nvidia reported a 106% increase in total revenue to $96 billion, with more than 90% of this being data center sales. And the global infrastructure ramp-up is driving this gain, Nvidia said. This is as tech giants turn to Nvidia for GPUs and other products needed in their data centers. Nvidia has been rolling out its latest platform, Vera Rubin, which includes its first-ever stand-alone central processing unit (CPU). These chips, the sorts you'll find in any computer, are seeing a new growth opportunity with the birth of agentic AI -- they drive the software as it takes steps to solve problems.

Upcoming earnings reportsNow, let's return to the subject of this week's earnings reports. As mentioned, Microsoft, Alphabet, and Amazon are scheduled to reveal their latest numbers -- and these three companies are Nvidia customers. Which number should Nvidia investors look to? That would be capital expenditures. Any increase in capex or messages of ongoing heavy spending in the year to come would represent excellent news for Nvidia. It would suggest that these companies will have more to spend on Nvidia's GPUs and systems.

All three companies had something to say about capex in their previous earnings reports: Microsoft offered capex guidance for fiscal year 2027, which started on July 1, and that number is $175 billion. Alphabet expects capex levels for the full year 2026 in the range of $195 billion to $205 billion, up from an earlier estimate of $180 billion to $190 billion. And Amazon increased its cash capex forecast for this year by $20 billion to $220 billion. Each company also spoke of high demand as the major driver for these investments and forecasts. In fact, demand is generally surpassing capacity, in spite of the billions of dollars these companies are pouring into infrastructure expansion.

Considering those recent messages, there's reason for Nvidia investors to be optimistic this time around too. Still, headwinds could emerge at any point, and any slowing of investment would be bad news for Nvidia, at least in the short term. That's why it's important for Nvidia investors to watch the capex trends and demand messages from big tech. This offers us clues about what's to come in Nvidia's next earnings report, in November.

These infrastructure companies will be in the spotlight later this week -- and that means Nvidia will be too.
2026-10-27 13:46 1d ago
2026-10-27 04:36 1d ago
Hourglass Capital zvýšil svůj podíl v AT&T o 20,4 %
T AT&T
FMP Stock News 78
Original source text
Hourglass Capital LLC grew its stake in shares of AT&T Inc. (NYSE:T – Free Report) by 20.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 258,490 shares of the technology company’s stock after acquiring an additional 43,750 shares during the quarter. Hourglass Capital LLC’s holdings in AT&T were worth $6,307,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Orion Capital Management LLC bought a new position in AT&T in the second quarter valued at about $26,000. Addison Advisors LLC bought a new position in shares of AT&T in the second quarter worth approximately $27,000. Fairway Wealth LLC purchased a new stake in shares of AT&T in the first quarter worth $29,000. Robinswood Financial LLC purchased a new stake in shares of AT&T in the first quarter worth $29,000. Finally, Matrix Trust Co raised its position in shares of AT&T by 331.8% during the 2nd quarter. Matrix Trust Co now owns 1,494 shares of the technology company’s stock valued at $31,000 after purchasing an additional 1,148 shares during the period. 57.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In A number of equities research analysts have commented on T shares. TD Cowen reissued a “hold” rating and set a $33.00 price target on shares of AT&T in a report on Thursday, October 22nd. Weiss Ratings raised AT&T from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, August 3rd. Royal Bank Of Canada cut their target price on AT&T from $31.00 to $27.00 and set an “outperform” rating for the company in a research report on Monday, July 20th. Barclays cut their target price on AT&T from $24.00 to $21.00 and set an “equal weight” rating for the company in a research report on Thursday. Finally, Sanford C. Bernstein downgraded AT&T from an “outperform” rating to a “market perform” rating and set a $24.00 target price on the stock. in a research note on Tuesday, October 13th. Twelve analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $28.55.

View Our Latest Stock Report on T AT&T Price Performance AT&T stock opened at $20.83 on Tuesday. The firm has a 50-day moving average price of $24.76 and a 200-day moving average price of $25.04. The firm has a market capitalization of $140.30 billion, a PE ratio of 11.26, a price-to-earnings-growth ratio of 1.04 and a beta of 0.25. The company has a current ratio of 0.87, a quick ratio of 0.82 and a debt-to-equity ratio of 1.22. AT&T Inc. has a 12-month low of $19.89 and a 12-month high of $29.43.

AT&T (NYSE:T – Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The technology company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.60 by $0.05. AT&T had a net margin of 10.19% and a return on equity of 13.41%. The company had revenue of $32.32 billion for the quarter, compared to the consensus estimate of $31.69 billion. During the same period in the prior year, the firm posted $0.54 EPS. The firm’s revenue was up 5.2% compared to the same quarter last year. As a group, equities research analysts forecast that AT&T Inc. will post 2.39 EPS for the current year.

AT&T Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Monday, October 12th will be issued a $0.2775 dividend. This represents a $1.11 annualized dividend and a dividend yield of 5.3%. The ex-dividend date is Friday, October 9th. AT&T’s dividend payout ratio is presently 60.00%.

AT&T Profile (Free Report)

AT&T Inc (NYSE: T) is a telecommunications company that provides wireless communications, broadband, and related connectivity services. Its offerings include mobile voice and data plans, internet access, fiber broadband, fixed wireless services, and business communications solutions.

The company serves consumers, businesses, government agencies, and other organizations primarily in the United States. AT&T’s business operations include wireless network services, wireline connectivity, fiber-optic internet, voice services, and networking solutions designed to connect locations, devices, and applications.

AT&T traces its history to the Bell System and has operated under its current corporate name since 2005, following the acquisition of AT&T Corp.

Featured Articles Five stocks we like better than AT&T Comfort Systems Earnings: AI Slowdown or More Growth Ahead? Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants

Receive News & Ratings for AT&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AT&T and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 13:46 1d ago
2026-10-27 08:39 1d ago
Akcie Procter & Gamble letos překonávají index S&P 500
PG Procter & Gamble
FMP Stock News 78
Original source text
Defensive consumer staples stocks are back in the limelight, with the sector on pace for its best monthly showing in 28 years.

Count Procter & Gamble (PG -0.68%) among the contributors to the sector's strength. One of the largest consumer staples companies by market cap, P&G was up 15.6% year-to-date as of Oct. 23, a 320-basis-point advantage over the S&P 500. Another fun fact about the Tide maker's 2026 showing: It's one of just 13 Dow Jones Industrial Average components up at least 10% this year.

Procter & Gamble is hot and it might be able to keep outpacing the broader market. Image source: Getty Images.

Shares of the Gillette parent certainly have the potential to continue outpacing the broader market. This Dividend King -- a company with a dividend increase streak of at least 50 years -- yields 2.7%. That's more than double the yield on the S&P 500. Factor in the stock's impressive 2026 run and some investors may be drawn to Procter & Gamble over higher-yielding Treasuries because the former has the potential to deliver more long-term upside.

Plus, there's no telling how long market participants will remain skittish about the artificial intelligence (AI) trade. To be sure, those jitters are playing a big role in driving consumer staples stocks, including P&G, higher.

$159.92-$1.10 (-0.68%)

NYSE · As of 4:00 PM ET 10/26/26

Still, investors who are mulling P&G today have some important points to ponder. First, the broader consumer staples sector is richly valued. Recently, the S&P 500 Consumer Staples Index, of which P&G is a member, sported a higher price-to-earnings ratio (P/E ratio) than the equivalent technology index.

Valuation alone isn't a reason to buy or sell a stock, but there's something else to consider. Some experts believe that the rotation out of tech stocks into defensive stocks may be a warning sign of looming weakness for the broader market. Maybe that prediction proves accurate. Maybe it doesn't. But if it does, the outperformance of staple stocks, including P&G, may simply be a case of "less bad."

Todd Shriber has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-10-27 13:44 1d ago
2026-10-27 08:11 1d ago
Hilton překonal odhady zisku, tržby zaostaly za očekáváním
HLT Hilton
FMP Stock News 88
Original source text
Hilton Worldwide Holdings Inc. (HLT - Free Report) came out with quarterly earnings of $2.45 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.11 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.81%. A quarter ago, it was expected that this company would post earnings of $2.29 per share when it actually produced earnings of $2.29, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Hilton Worldwide, which belongs to the Zacks Hotels and Motels industry, posted revenues of $3.33 billion for the quarter ended September 2026, missing the Zacks Consensus Estimate by 1.93%. This compares to year-ago revenues of $3.12 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Hilton Worldwide shares have added about 22.5% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Hilton Worldwide?While Hilton Worldwide has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Hilton Worldwide was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.45 on $3.38 billion in revenues for the coming quarter and $9.09 on $13.03 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Hotels and Motels is currently in the bottom 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Hilton Grand Vacations (HGV - Free Report) , is yet to report results for the quarter ended September 2026. The results are expected to be released on October 29.

This company is expected to post quarterly earnings of $1.01 per share in its upcoming report, which represents a year-over-year change of +68.3%. The consensus EPS estimate for the quarter has been revised 3% higher over the last 30 days to the current level.

Hilton Grand Vacations' revenues are expected to be $1.41 billion, up 8.7% from the year-ago quarter.
2026-10-27 13:44 1d ago
2026-10-27 07:02 1d ago
PayPal zvýšil celoroční výhled upraveného zisku
PYPL PayPal
FMP Stock News 97
Original source text
PayPal (PYPL.O) lifted its annual adjusted profit forecast on Tuesday, as ​a years-long turnaround starts to bear fruit, with improving margins and resilient consumer spending providing fresh momentum.

The company ‌has stepped up efforts to revive growth, most recently under CEO Enrique Lores, as it struggles to sustain its pandemic-era popularity amid intense competition from Apple and Google and newer fintechs.

"We are making good progress in our multi-year transformation," Lores, who took the helm earlier this year ​after the board ousted Alex Chriss over dissatisfaction with the pace of change and execution, said in a ​statement.

"While there is more work to do, we are increasingly confident in our path to ⁠durable, profitable growth and remain focused on execution," he added.

The payments company now expects full-year adjusted profit of about $5.60 ​per share, compared with its previous forecast and Wall Street analysts' expectations of $5.38, according to estimates compiled by LSEG.

Adjusted profit ​came in at $1.45 per share in the three months ended September 30, sailing past estimates of $1.31.

Revenue of $8.6 billion in the third quarter was a tad below estimates of $8.7 billion. Shares of the company fell 1.2% in premarket trading.

REVIVAL ON TRACK
The company said it was on track ​to achieve $700 million in gross run-rate cost savings by the end of 2026, driven by cuts to more than ​2,000 jobs and a reduction of over 25% in managerial roles.

Efforts to streamline operations, optimize its portfolio and accelerate AI adoption, including ‌using AI ⁠chat agents to support customer service, are also supporting the cost-management efforts, PayPal said.

The company has set a goal of securing at least $1.5 billion in gross run-rate savings over the next two to three years.

Adjusted operating margin, a key metric for investors, expanded 16 basis points to 18.8% in the third quarter.

Earlier this year, Reuters reported, citing sources, that PayPal ​had received a buyout offer of $60.50 ​per share from Stripe ⁠and private equity firm Advent International, a bid that many analysts described as "low-ball."

The offer, which valued PayPal at about $53 billion, was reportedly deemed inadequate by the board and represented a fraction ​of the roughly $360 billion valuation the company commanded at its peak in 2021.

SPENDING ENGINE ​KEEPS HUMMING
More broadly, ⁠US consumers have continued to open their wallets despite economic uncertainty and sticky inflation, helping sustain spending growth across the payments industry.

PayPal's total payment volume grew 7% on a foreign exchange-neutral basis to $487.1 billion in the third quarter.

The year-end holiday season brings a ⁠crucial ​sales period for the payments sector, as retailers roll out eye-catching discounts ​and doorbuster deals online and in stores for Black Friday, Cyber Monday and Christmas.

PayPal expects adjusted profit in the fourth quarter to come in at $1.43 ​per share, well above Street expectations of $1.35 and $1.23 a year earlier.
2026-10-27 13:43 1d ago
2026-10-27 09:00 1d ago
Anduril a Qualcomm představily odolný notebook BlueChip
QCOM Qualcomm
FMP Stock News 72
Original source text
Anduril founder Palmer Luckey is vowing to bring computer manufacturing back to the U.S. And by that, he doesn’t just mean assembly, but the production of every individual component, some of which are exclusively made in China today.

Anduril is partnering with Qualcomm to achieve that mission with a new computer called BlueChip, the companies announced Tuesday. BlueChip will be available for preorder in 2027.

While technical details are scant — Anduril hasn’t even finished contracting with all its component suppliers yet, according to Luckey — this first product will be a hardened laptop. It will be designed to withstand the most grueling physical environments and meet the security-conscious needs of the military, government, first responders and law enforcement.

For the first generation, about 90% of its components will be made in the U.S. or in allied countries, Anduril says, most notably its CPU. BlueChip will run on a Snapdragon X Series built at TSCM’s massive new facility in Arizona. The CPU uses the same architecture that powers other laptops, including the Microsoft Surface, Qualcomm CEO Cristiano Amon said during the press conference.

“As of right now, the laptop’s bill of materials is about 90% U.S. and allied [ally countries], and we have a technical roadmap to get to 100% domestic over time,” Luckey said. “The intent in the long run is to have an option that is made entirely in the United States, 100% domestic. And I mean everything. I mean the displays. I mean the metallics. I mean the the magnetics. All of it.”

Right now, for instance, Luckey says he’s found an American supplier for the glass that covers the display, but the display itself is one of several components he says are only manufactured in China.

Anduril’s BlueChip computerImage Credits:Anduril While Luckey says consumers are welcome to order a BlueChip — the company may even create a waiting list for interested consumers — this first PC won’t be designed for them. For one thing, as a hardened computer, it will be heavy and have battery-life constraints because of the engineering required to withstand rain, dust, and other rugged conditions.

The bigger point is to offer U.S. government agencies a product that complies with regulations requiring them to buy U.S.-made computers. In this case, the selling point is a transparent supply chain that customers can track and audit.

“These computers are the anti-surveillance computer. You fully control it,” Luckey described in a recent interview. “You know everything that is in it, every single component, and you know every software component that is running on it.”

Anduril is also working to ensure that the Arm-based machine works well with Windows apps, apps built for certain Linux distributions used by the government, and even archaic software that various agencies still run.

While Anduril hasn’t yet announced pricing, Luckey estimates it will cost about 20% more than typical high-end PCs.

“As much as I love BlueChip, if I was just a normal consumer making a rational decision without a kind of patriotic basis, I’d be better off buying a Dell laptop than an Anduril laptop because it’s going to be cheaper. I’m just talking about your average person consumer, right, who doesn’t have any real need for this,” Luckey said.

But Luckey clearly hopes Anduril will eventually make U.S.-made laptops more in line with consumer desires. He said the product is the first in what he envisions as a full line of BlueChip computers, noting that he began his career making devices virtual reality headsets for consumers.

“I’m buying American cars, and then I buy a computer that’s made on the other side of the world, not just China, but you know, Japan, Korea,” he said. “It’s kind of humiliating that as an American and my birthright is computers, in my opinion, because America invented them, that I’m not able to buy an American computer.”

As for the potentially expensive folly of trying to take on China’s electronics components manufacturing industry single-handedly, Luckey joked about his internal reputation for “being a nut” with such big ideas. (He admits that he pushed his board to spend $900 million to build a factory for a jet before the company had even won a contract.)

“This is not one of those things. My investors do not think I’m a crazy person in this particular area,” he said. In fact, rugged computers are already about a $5 billion market.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
2026-10-27 13:43 1d ago
2026-10-27 09:11 1d ago
William Blair snížila doporučení pro společnost Moderna kvůli ocenění
MRNA Moderna
FMP Stock News 90
Original source text
Moderna Inc. (NASDAQ:MRNA) shares are trading lower Tuesday after William Blair downgraded the stock to Market Perform from Outperform on Monday, citing valuation concerns.

Moderna stock is among today’s weakest performers. What’s pressuring MRNA stock? William Blair Downgrades Moderna on Valuation After a 545% Rally This YearAccording to Investing.com, William Blair analyst Myles Minter cited valuation concerns after the stock rose 545% this year and nearly 250% since positive trial news in August. Moderna has a market value of $79.4 billion, though shares have pulled back 17.9% over the past week. Minter said the firm believes interim data from the Phase 3 INTerpath-001 trial of intismeran plus pembrolizumab in adjuvant melanoma, presented at the ESMO Congress, supports a potential new standard of care if Merck and Moderna can roll out the personalized neoantigen vaccine commercially. William Blair is moving to Market Perform while it does more work on other tumor types.

William Blair Says Other Tumor Types Will Decide Whether Intismeran Is Limited to MelanomaMinter said investors will now focus on whether intismeran can treat other tumors, including renal, bladder and lung cancers, which will determine if its commercial potential compares to checkpoint inhibitors or is limited to melanoma. William Blair models $5.4 billion in peak melanoma sales, subject to a 50:50 profit share, while Keytruda is predicted to reach $35 billion in 2028 before it loses patent protection. The firm’s sum-of-the-parts analysis implies a 70% to 75% probability of success across additional tumor types, for a total net present value just above Moderna’s current market cap. Minter noted that development in those tumors carries meaningful clinical and biological risk. Phase 2 trials in renal and bladder cancer are expected in 2027.

Read Next

Moderna Shares DropMRNA Price Action: At the time of publication, Moderna shares are trading 3.05% lower at $192.79, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
2026-10-27 13:43 1d ago
2026-10-27 08:00 1d ago
Teva získala práva na BXCL501 za 57,5 milionu USD
TEVA Teva Pharmaceutical
FMP Stock News 95
Original source text
BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adultsAcquisition adds differentiated late-stage investigational asset with potential to address a significant unmet need for patientsTransaction supports Teva’s Pivot to Growth strategy and the company’s disciplined approach to business development TEL AVIV, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that it has completed the acquisition of assets from BioXcel Therapeutics, Inc., including worldwide rights to BXCL501. BXCL501 is an investigational dexmedetomidine sublingual film under FDA review for at-home use in the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. If approved, BXCL501 would be the first FDA-approved treatment patients could use at home for this condition. The acquisition expands Teva’s innovative neuroscience pipeline with a late-stage asset with the potential to address a significant unmet patient need.

“Business development plays an important role in accelerating our Pivot to Growth strategy by bringing targeted external innovation into Teva,” said Evan Lippman, Executive Vice President, Business Development at Teva. “BXCL501 is a strong strategic fit with our neuroscience portfolio and reflects our disciplined focus on differentiated, late-stage opportunities that address unmet patient needs and create long-term value for Teva’s shareholders.”

Acute agitation associated with schizophrenia or bipolar I or II disorder affects between 25% and 40%1 of patients across these conditions. Acute agitation can escalate quickly, creating significant challenges for patients, families and caregivers and, in some cases, resulting in an emergency department visit or hospitalization. Acute treatment options remain limited, particularly outside healthcare settings.

“Agitation can escalate quickly, which is why the ability to intervene early matters,” said Eric Hughes, M.D., Ph.D., Executive Vice President, Global R&D and Chief Medical Officer at Teva. “If approved, BXCL501 could give adults living with schizophrenia or bipolar I or II disorder the ability to treat agitation at home, closer to the moment symptoms emerge and before they could become more difficult to manage.”

About the Transaction
Teva acquired the neuroscience assets of BioXcel Therapeutics, Inc. and its affiliates through a court-supervised sale process under Section 363 of the U.S. Bankruptcy Code. The assets include worldwide rights to BXCL501 and IGALMI® (dexmedetomidine), an FDA-approved dexmedetomidine sublingual film for the treatment of agitation associated with schizophrenia or bipolar I or II disorder in a hospital setting. The application for the approval of BXCL501 has been submitted as a supplemental New Drug Application (NDA) to the IGALMI® NDA. The transaction does not involve the acquisition of BioXcel Therapeutics.

The transaction closed following Teva’s selection as the successful bidder, approval by the U.S. Bankruptcy Court and satisfaction of other closing conditions.

Teva acquired the assets for $57.5 million upfront and up to $67.5 million in contingent payments. These include a range of time-based payments linked to regulatory approval, including potential delays in approval, as well as payments tied to the achievement of specified sales milestones.

About dexmedetomidine sublingual film (BXCL501)
Dexmedetomidine is a selective alpha-2 adrenergic receptor agonist. BXCL501 is a proprietary, investigational, orally dissolving film formulation currently under FDA review for potential at-home use in the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars, and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Teva Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause Teva’s future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, you can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “developing,” “target,” “may,” “expand,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future performance. Important factors that could cause or contribute to such differences include risks and uncertainties relating to: our ability to successfully integrate and realize the anticipated benefits of the acquired assets from BioXcel Therapeutics, Inc.; resolution of any applicable appeals to the bankruptcy sale order approving the transaction; ability to obtainability to obtain regulatory approval for and successfully commercialize the novel dexmedetomidine sublingual film; our ability to obtain regulatory approval for and successfully commercialize the novel dexmedetomidine sublingual film; our ability to successfully compete in the marketplace including our ability to develop and commercialize ecopipam and additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments; and other factors discussed in this press release and in our Quarterly Report on Form 10-Q for the second quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the section captioned “Risk Factors” and “Cautionary Note Regarding Forward Looking Statements.”

Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries: [email protected]
Teva Investor Relations Inquiries: [email protected]

1 Teva Market Research via Trinity Partners, March 2026.
2026-10-27 13:39 1d ago
2026-10-27 07:00 1d ago
Spready dluhopisů Oracle překonaly průměr pro rating BB
ORCL Oracle Corp
FMP Stock News 88
Original source text
Oracle's bonds are now trading wider than the average junk-rated debt, and the fallout reaches further than most retirees realize. If you keep your "safe" money in a bond fund, there are three things worth checking before your next withdrawal.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Picture a 62-year-old with $100,000 of her 401(k) parked in an intermediate bond fund. She thinks of it as the steady part of her retirement savings, the money that won’t swing with every market headline. Then comes the reality check about Oracle’s bonds, calling that sense of security into question.

Oracle’s Bond Spreads Now Exceed Those of Average BB-Rated Debt Oracle’s (NYSE: ORCL | ORCL Price Prediction) investment-grade bonds have come under pressure as investors question the borrowing needed to bankroll AI expansion. According to BondTerminal, the spread on Oracle’s 4.95% bonds due in 2031 stood at 263 basis points over government debt on Oct. 23. Reuters also reported that the cost of insuring Oracle debt against default had climbed to 288 basis points on Oct. 15, reflecting growing concern among lenders.

A spread is the extra yield lenders demand to own one company’s bonds instead of Treasuries. Oracle still holds an investment-grade rating. Even so, the Journal pointed to Bloomberg data showing that double-B bonds, the tier just below investment grade, averaged a spread of only 2.06 percentage points. In this comparison, Oracle’s bonds carry a wider spread than the average BB-rated bond, despite its higher credit rating.

Investors told the Wall Street Journal they worry about future demand for AI computing and about how many more AI bonds are coming. Bonds from SpaceX and Meta Platforms (NASDAQ:META) widened as well. For background, Oracle said in February it planned to raise $45 billion to $50 billion in 2026, with about half coming from a single investment-grade bond sale and half from equity.

Oracle’s latest quarter shows why lenders are conservative. Capital spending hit $28.5 billion, pushing free cash flow to negative $5.4 billion, while interest expense rose 55%. Shares are down 34% this year.

Two Forces That Shrink a Bond Fund With Zero Defaults Bond funds face two major risks. Credit spreads reflect the extra yield investors demand for taking on an issuer’s risk, while interest-rate risk comes from changes in market yields. Either can push existing bond prices lower without a single default. Duration helps measure how sensitive those prices are to changes in yields.

Duration turns that into napkin math. As an illustration only, $100,000 in bonds with a 6-year duration would lose roughly $6,000 if yields rose one percentage point, all else equal. That figure is a teaching example, separate from her actual loss.

Rising Treasury yields have added pressure this year. The 10-year yield ended 2025 at 4.18% and reached 5.00% on Oct. 26. If her fund’s yields had climbed by that same 0.82 percentage point, the six-year duration illustration would suggest a roughly $4,920 price decline before interest income. Her actual return would depend on the fund’s holdings, changing credit spreads and other factors.

How Much One Issuer Can Move Her Balance A single issuer affects a diversified fund in proportion to its exposure. Suppose Oracle accounted for 1% of her fund, or $1,000 of her $100,000 balance. If those bonds had a six-year spread duration, a full percentage-point widening in Oracle’s credit spread would erase roughly $60 in market value.

Her larger exposure is cumulative. Many broad bond indexes weight securities by their market value, which often gives heavily indebted companies a larger presence as they borrow more. Combine several of those issuers on top of rate sensitivity she has never measured, and the fund she thought was frozen starts to shift.

Timing makes this matter at 62. If she needs to sell bond-fund shares to cover retirement withdrawals during a downturn, she could lock in losses before prices recover. That’s one form of sequence-of-returns risk, and we walked through how to defend those first few years of withdrawals in a free guide here.

Three Checks to Run Before Your Next Withdrawal Check the fund’s holdings and credit breakdown. Look for its largest issuers and the share of bonds rated BBB, the lowest investment-grade tier. A concentration of heavily indebted technology companies could make the fund more sensitive to headlines like Oracle’s. Convert duration into dollars. Multiply your bond balance by the fund’s duration and divide by 100 to estimate the price decline from a one-percentage-point rise in yields. Compare that potential loss with your upcoming spending needs before deciding how much rate risk you can afford. Scan the plan menu for shorter options. Short-term bond funds and stable-value options may offer less price volatility. TIPS funds provide inflation protection but can still lose value when real yields rise. Money earmarked for near-term spending deserves investments that limit the risk of having to sell at a loss. Once she knows her fund’s duration and top issuers, the next Oracle development stops being a surprise and becomes a number she has already budgeted for.

Contact [email protected] for any questions or corrections.
2026-10-27 13:39 1d ago
2026-10-27 09:16 1d ago
American Tower překonala odhady FFO i tržeb
AMT American Tower
FMP Stock News 88
Original source text
American Tower (AMT - Free Report) came out with quarterly funds from operations (FFO) of $2.87 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to FFO of $2.78 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an FFO surprise of +1.06%. A quarter ago, it was expected that this wireless communications infrastructure company would post FFO of $2.71 per share when it actually produced FFO of $2.71, delivering no surprise.

Over the last four quarters, the company has surpassed consensus FFO estimates three times.

American Tower, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $2.79 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 0.44%. This compares to year-ago revenues of $2.72 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.

American Tower shares have added about 7.2% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for American Tower?While American Tower has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for American Tower was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $2.78 on $2.79 billion in revenues for the coming quarter and $11.11 on $11.04 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Cousins Properties (CUZ - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on October 29.

This real estate company is expected to post quarterly earnings of $0.73 per share in its upcoming report, which represents a year-over-year change of +5.8%. The consensus EPS estimate for the quarter has been revised 0.7% higher over the last 30 days to the current level.

Cousins Properties' revenues are expected to be $258.7 million, up 5% from the year-ago quarter.
2026-10-27 13:38 1d ago
2026-10-27 08:11 1d ago
UPS překonala odhady zisku i tržeb
UPS UPS
FMP Stock News 88
Original source text
United Parcel Service (UPS - Free Report) came out with quarterly earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.74 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.68%. A quarter ago, it was expected that this package delivery service would post earnings of $1.65 per share when it actually produced earnings of $1.76, delivering a surprise of +6.67%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

UPS, which belongs to the Zacks Transportation - Air Freight and Cargo industry, posted revenues of $22.85 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 2.70%. This compares to year-ago revenues of $21.42 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

UPS shares have added about 1.1% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for UPS?While UPS has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for UPS was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.74 on $25.52 billion in revenues for the coming quarter and $7.19 on $91.71 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Transportation - Air Freight and Cargo is currently in the top 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

GXO Logistics (GXO - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2026. The results are expected to be released on November 3.

This contract logistics provider is expected to post quarterly earnings of $0.86 per share in its upcoming report, which represents a year-over-year change of +8.9%. The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level.

GXO Logistics' revenues are expected to be $3.56 billion, up 4.8% from the year-ago quarter.
2026-10-27 13:38 1d ago
2026-10-27 08:45 1d ago
Costco zůstává doporučením „držet“ kvůli vysokému ocenění
COST Costco Wholesale
FMP Stock News 88
Original source text
Costco just posted its fifth straight earnings beat and rewarded shareholders with a strong monthly gain, yet its valuation leaves almost no room for anything less than flawless execution. Before adding shares near four figures, here is what the numbers…

Costco (NASDAQ:COST | COST Price Prediction) is a Hold at $1,005.16. The stock has gained 8.93% over the past month after a fifth consecutive quarterly beat, and that rally puts its premium valuation back under the microscope.

Costco runs 939 warehouses across 14 countries and territories, serves 150.4 million cardholders, and sells the Kirkland Signature private label. Fiscal 2026 revenue reached $303.15 billion, up 10.14%, with EPS of $20.76. Shares still trade below the $1,094.76 52-week high.

Sticky Memberships and Rising Estimates Power the Bull Case
Renewal rates reached 92.3% in the U.S. and Canada and 89.8% worldwide, while paid executive members grew 9.4% to 42.3 million. Digitally enabled comparable sales rose 19.5%, and free cash flow climbed 19.82% to $9.39 billion.

Analysts keep raising numbers. Fiscal 2027 EPS estimates drew 18 upward revisions versus 4 downward over 30 days, with consensus at $22.8083, roughly 9.9% growth. Costco plans 33 openings in fiscal 2027 and sees a path to roughly 30 new warehouses a year for the next five to ten years. The CFO added there is nothing that “prevents continued leverage if comps remain in the mid-single digits.”

A 48x Multiple Leaves Little Margin for Error
Costco trades at a trailing P/E of 48, a forward P/E of 40, and a PEG ratio of 4.381. That pricing assumes perfect execution. Fourth-quarter EPS included a $0.15 per share nonrecurring tariff refund benefit, and management plans to reinvest most future refunds in prices, which complicates fiscal 2027 comparisons.

Costs are rising too. Capex is expected to reach $7.5 billion in fiscal 2027, the quarterly LIFO charge jumped to $152 million from $43 million, and total paid members grew just 3.8%, a pace management called “probably typical.”

Elite Execution Meets a Full Price Tag
Traffic up 3.3% and record executive penetration rule out a Sell. The valuation and moderating membership growth rule out a Buy. Upside conviction would require faster membership growth from Asia openings or a decline toward the $840.35 52-week low. Comparable sales falling below the mid-single digits ex-gas would shift the call toward Sell. The fiscal first-quarter EPS consensus is $4.9097.

Shares Outpace the S&P 500 as Target Upside Narrows
Shares are currently priced at $1,005.16, against an average analyst target of $1,067.59, meaning 6.2% upside. Targets are only a rough guide and carry no guarantee. Among 39 analysts, ratings break down as:

Strong Buy: 4
Buy: 20
Hold: 13
Sell: 1
Strong Sell: 1

Costco rose 8.93% over the past month while the S&P 500 slipped 0.78%. Year to date, Costco is up 17.08% versus 12.23% for the index. Over one year, the stock gained 8.46%, trailing the S&P 500’s 13%. Beta is 0.87.

Costco Earns a Hold Until Price or Growth Catches Up
At $1,005.16, Costco is a Hold.

The business keeps growing, yet the stock already prices in steady execution. With only 6.2% implied upside to consensus targets, the upside looks thin relative to multiple compression risk.

Over the next two to three quarters, the key signals are core comparable sales ex-gas, membership growth, and gross margin once tariff refunds roll off. A decline toward the 200-day moving average of $969.35 combined with steady comps would improve the valuation picture. The stock is supported by a forward dividend of $5.88 and Costco’s defensive profile.

Costco remains a top-tier retailer whose share price already reflects that quality, so further upside depends on a lower price or faster growth.

Contact [email protected] for any questions or corrections.
2026-10-27 13:37 1d ago
2026-10-27 08:00 1d ago
AbbVie žádá FDA o schválení etentamigu
ABBV AbbVie
FMP Stock News 95
Original source text
–  Etentamig is a second-generation BCMA-directed bispecific antibody T-cell engager with a clinical profile and dosing schedule that can potentially support treatment across a broad range of settings, including in community-based care
–  In the Phase 3 CERVINO study, etentamig achieved statistically significant improvements in overall response rate (ORR) and progression-free survival (PFS) versus investigator's choice of standard available therapies
–  Submission underscores AbbVie's ambition to advance a broad multiple myeloma portfolio that addresses disease complexity and supports patients' evolving care goals 

, /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for etentamig, a second-generation BCMA x CD3 bispecific antibody T-cell engager administered intravenously for the treatment of adults with relapsed or refractory multiple myeloma.1

BCMA-directed bispecific antibodies and CAR-T therapies have significantly changed the treatment landscape for people living with multiple myeloma.2 However, their broader adoption may be limited by adverse events such as cytokine release syndrome, infections or neurotoxicity, as well as specialized administration and monitoring requirements.2,3,4 Additionally, as disease relapses, treatment options in later lines of therapy become increasingly limited. Together, these factors highlight the need for additional therapies that may address the biology of the disease and help support effective treatment delivery across diverse care environments.2,3,4

"Multiple myeloma is a chronic blood cancer that can reshape a person's life. Patients deserve therapeutic options that are not only effective, but also support the realities of when, where and how they receive treatment," said Daejin Abidoye, M.D., vice president and therapeutic area head, oncology, solid tumor and hematology, AbbVie. "This milestone brings us a step closer to potentially delivering a novel, patient-centered treatment option with a manageable safety profile and the convenience of a monthly dosing schedule that can help meet the needs of people living with multiple myeloma wherever they receive care."

The submission is supported by results from the global, Phase 3, multicenter, randomized CERVINO study evaluating etentamig versus investigator's choice of standard available therapies (SAT) in patients with triple-class exposed relapsed or refractory multiple myeloma who had received at least two prior lines of therapy.5 Topline results were announced earlier this year.

The findings indicated that etentamig achieved statistically significant improvements across the dual primary endpoints of overall response rate (74.0% vs. 45.7%) and progression-free survival (60% risk reduction) versus SAT.5The most common treatment-emergent adverse events (TEAEs) reported in the etentamig arm of the study (≥ 25%) included cytokine release syndrome (CRS), hypogammaglobulinemia, neutropenia and anemia.5Discontinuations related to TEAEs were low for etentamig vs. SAT (3.6% vs. 14%).5With monthly dosing from initiation, etentamig demonstrated a potentially differentiated safety profile.5Among patients receiving a single step-up dose, the incidence of CRS was low (28.3%), all being grade 1 (23.9%) or grade 2 (4.4%) and no grade 3 or higher events were reported.5 One patient experienced an immune effector cell-associated neurotoxicity syndrome (ICANS) event (grade 1).Among all etentamig patients, grade 3/4 infections occurred in 27.7% versus 19.2% in patients receiving SAT.5 Importantly, grade 5 infections were observed less frequently in patients treated with etentamig (1.5%) versus SAT (3.1%).About Multiple Myeloma

Multiple myeloma is a chronic blood cancer that affects white blood cells, called plasma cells, in the bone marrow.6 It causes these cells to grow and crowd out healthy cells that help fight infection.6 In 2025, an estimated 36,000 people were diagnosed with multiple myeloma in the U.S.7 The disease commonly presents with non-specific symptoms that may resemble other conditions, leading to delays in diagnosis and treatment.8 People living with multiple myeloma and their caregivers often face substantial physical, emotional and economic burden.9

About the Phase 3 CERVINO Study5

The Phase 3 CERVINO trial (NCT06158841) is a global, multicenter, randomized, open-label study evaluating etentamig versus investigator's choice of standard available therapies (SAT) in triple-class exposed patients with relapsed/refractory multiple myeloma (RRMM) who have received at least two prior lines of therapy, including exposure to a proteasome inhibitor, an immunomodulatory drug and an anti-CD38 monoclonal antibody. A total of 393 patients were randomized 1:1 to receive etentamig or SAT, including carfilzomib plus dexamethasone, elotuzumab plus pomalidomide and dexamethasone, or selinexor plus bortezomib and dexamethasone. Etentamig was administered using an optimized dosing strategy that incorporates a single step-up dose followed by monthly (Q4W) dosing from initiation.

The dual primary endpoints are overall response rate and progression-free survival. Key secondary endpoints include overall survival, depth of response, measurable residual disease (MRD) negativity, disease symptoms and physical functioning.

About Etentamig

Etentamig (ABBV-383) is an investigational, second-generation BCMA x CD3 bispecific antibody T-cell engager designed to combine meaningful anti-myeloma activity with a differentiated treatment experience for patients. Etentamig is composed of a low-affinity CD3 binding domain, designed to reduce cytokine release syndrome and infections, a high-affinity bivalent BCMA-binding domain, and retained FcRn binding enabling Q4W dosing after a single step-up dose. The direct connection between these structural findings and clinical effects is currently being investigated.10

BCMA is highly expressed on the surface of malignant plasma cells in multiple myeloma, making it a key target for therapy. BCMA plays a crucial role in the survival of myeloma cells by promoting their growth and inhibiting their apoptosis (programmed cell death).11

Several clinical studies are evaluating the potential of etentamig across diverse patient populations and treatment settings. To learn more about AbbVie's ongoing etentamig clinical trials, please visit clinicaltrials.gov. 

About AbbVie in Oncology 

AbbVie is committed to elevating standards of care and bringing transformative therapies to patients worldwide living with difficult-to-treat cancers. We are advancing a dynamic pipeline of investigational therapies across a range of cancer types in both blood cancers and solid tumors. We are focusing on creating targeted medicines that either impede the reproduction of cancer cells or enable their elimination. We achieve this through various, targeted treatment modalities and biology interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibodies and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.

Today, our expansive oncology portfolio comprises approved and investigational treatments for a wide range of blood cancers and solid tumors. We are evaluating more than 35 investigational medicines in multiple clinical trials across some of the world's most widespread and debilitating cancers. As we work to have a remarkable impact on people's lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, please visit http://www.abbvie.com/oncology.

About AbbVie 

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube. 

Forward-Looking Statements  

Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

References

AbbVie. Data on file ABVRRTI83865.Hej-Ali S, Banwell K, Mohamed H, et al. Toxicities of CAR-T, bispecific antibodies, and antibody-drug conjugates in multiple myeloma: a practical approach to risk mitigation and management. Cancers (Basel). 2026;18(13):2083.Benda M, Reimann P, Willenbacher W, et al. Infectious toxicities associated with bispecific antibodies and CAR-T cells in multiple myeloma: a systematic review. Ann Hematol. Published online June 18, 2026.Graham T, Ackbarali T, Patel K, Richter J. Integrating bispecific antibodies into community myeloma care: challenges, insights, and educational impact. Blood. 2025;146(suppl 1):8134.Voorhees P, Manteca V, Costa L, et al. "CERVINO: Phase 3 Results of Etentamig vs. Investigator's Choice of Standard Available Therapies in Triple-Class Exposed Relapsed or Refractory Multiple Myeloma (RRMM)." Abstract presented at International Myeloma Society Annual Meeting, 2026. Glasgow, Scotland.Cleveland Clinic. Multiple Myeloma: Symptoms, Causes & Treatment. Updated August 18, 2025. Available at: https://my.clevelandclinic.org/health/diseases/6178-multiple-myeloma. Accessed October 2026.American Cancer Society. Key Statistics About Multiple Myeloma. Last revised January 13, 2026. Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/key-statistics.html. Accessed October 2026.Zorlu T, Kayer MA, Okumus N, et. al. Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma. Diagnostics (Basel). 2025 Jul 4;15(13):1708.Gatopoulou X, Iraqi W, Morgan K, et. al. The Burden of a Multiple Myeloma Diagnosis on Patients and Caregivers in the First Year: Western European Findings. Clinicoecon Outcomes Res. 2022 Dec 17;14:731-753.D'Souza A, Shah N, Rodriguez C, et al. A phase I first-in-human study of ABBV-383, a B-cell maturation antigen × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma. J Clin Oncol. 2022;40(31):3576-3586.Graham T, Ackbarali T, Patel K, Richter J. Integrating bispecific antibodies into community myeloma care: challenges, insights, and educational impact. Blood. 2025;146(suppl 1):8134. SOURCE AbbVie
2026-10-27 13:36 1d ago
2026-10-27 08:00 1d ago
Lemonade spustila v Idahu pojištění nájemníků od 5 USD
LMND Lemonade
FMP Stock News 78
Original source text
Idaho Renters Can Now Get Fast, Affordable Coverage Starting at $5 Per Month

, /PRNewswire/ -- Lemonade (NYSE: LMND), the tech-first insurance company, today announced the availability of its renters insurance in Idaho. The expansion gives renters across the state a simple, fast way to get coverage that fits their lifestyles.

Lemonade Renters Insurance provides flexible coverage options via an app where Idaho residents can get quotes, purchase policies, update existing policies, and file claims, all in one place. More than 50% of claims are handled instantly, helping renters receive assistance more quickly after a covered loss. "We built Lemonade to cut through the complexity that makes traditional insurance painful. We offer simple quotes, instant claims, and rates that don't break the bank. Now we can deliver that to Idaho renters, too," said Dan Timsit, Head of Renters Insurance at Lemonade.

Coverage starts at just $5 per month, making it one of the more affordable renters insurance options available. Based on company and industry data, Lemonade's renters insurance rates are approximately 30% lower than the national average.

Customers may also be eligible for additional savings through policy bundling, having qualifying home safety devices, or choosing annual billing.

Lemonade currently serves more than 3 million active customers and has earned recognition from organizations and publications including Forbes, CNBC, and U.S. News & World Report for its insurance products and customer experience.

For a full list of Renters state availability, visit Lemonade.com.

About Lemonade

Lemonade's mission is to become the most loved insurance company in the world. As a customer-centric tech company, we created an insurance experience across Renters, Home, Pet, Car, and Life that is smart, instant, and delightful. Our team of 1,200+ Lemonade Makers make it possible for over 3M customers throughout the US, UK and Europe to get coverage instantly, with nearly half of claims paid in a matter of seconds. Powered by AI and social impact, Lemonade is a purpose-built, technology-first insurance carrier. A Certified B-Corp, our commitment to social impact is embedded in every aspect of the company, and our Giveback program, which donates a percentage of leftover premiums to nonprofits selected by our community, has donated over $10M to organizations in need.

SOURCE Lemonade, Inc.
2026-10-27 13:36 1d ago
2026-10-27 07:57 1d ago
Palantir těží z rychlého zavádění AI ve firmách
PLTR Palantir Technologies
FMP Stock News 84
Original source text
SummaryPalantir (PLTR) is reiterated as a Strong Buy ahead of its November 2nd earnings, driven by robust AI enterprise adoption trends. PLTR's value proposition centers on linking AI spending to tangible ROI, with sovereignty, compliance, and auditability as key differentiators. US commercial growth remains exceptional at 149%, with net dollar retention at 157% and strong customer expansion expected to continue. Key risks include execution missteps, potential AI budget cuts, and a premium valuation that demands flawless performance to sustain momentum. 358 Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of PLTR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-27 13:36 1d ago
2026-10-27 09:19 1d ago
Lyft před výsledky čelí tlaku na ziskovost
LYFT Lyft
FMP Stock News 85
Original source text
SummaryLyft, Inc. remains fundamentally attractive, with a compelling valuation despite competitive and long-term autonomous vehicle threats.I maintain a Hold rating ahead of earnings, expecting profitability pressures from promotions and macro headwinds, but would consider buying on a post-earnings selloff.Expensive cars and a challenging job market may provide near-term tailwinds for LYFT’s rider and driver growth, though execution is crucial.LYFT trades at a non-GAAP TTM P/E of 13.78 and Price/Sales of ~1, offering a discount versus Uber, with active rider growth and profitability key to monitoring. Getty Images

In my opinion, Lyft, Inc. (LYFT) remains one of the more fundamentally attractive tech stocks. Yes, the company faces distinct long-term threats, including the rollout of robotaxis. Yet that threat, for now, lies beyond the horizon. Uber (

1.48K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-27 13:35 1d ago
2026-10-27 07:24 1d ago
Poptávka humanoidních robotů po DRAM má do roku 2030 vzrůst 20krát
MU Micron Technology
FMP Stock News 84
Original source text
Counterpoint Research sees humanoid robot memory demand exploding this decade, but Elon Musk just cut memory on his own robot chips to hit production targets, and Micron investors are left wondering whether the 2030 forecast translates into revenue they can…

Elon Musk needed two words to dismiss a skeptic on X on October 26, 2026: “Silly analysis.” The Tesla (NASDAQ:TSLA | TSLA Price Prediction) chief executive posted the reply at 1:32 p.m. ET. It drew more than 1 million views and brought a memory forecast from earlier in the month back into discussion.

Counterpoint Research released that forecast on October 11, projecting that demand for DRAM from humanoid robots will rise about 20 times by 2030. DRAM is the working memory that holds data while a processor is using it.

Micron Technology (NASDAQ:MU) rose 2.98%, or $26.15, to $903.70 and traded at $913.25 after hours. Tesla gained 5.21% to $391.62 after Barclays (NYSE:BCS) upgraded it to Overweight with a $450 target, citing hopes for a SpaceX merger. For Micron shareholders, a very high growth rate on a small base can still barely register at a company that reported $54.23 billion of revenue in a single quarter.

What the Counterpoint Forecast Actually Measures Counterpoint Research projects humanoid DRAM demand rising from about 8,300 terabits in 2026 to about 172,000 terabits in 2030, an increase of 20.7x. Counterpoint Research also expects average DRAM per robot to grow from 19 gigabytes to 39 gigabytes.

Most of the growth therefore comes from building many more robots, each carrying somewhat more memory. The forecast covers DRAM only and leaves out storage chips.

X user @zephyr_z9 replied that the forecast implies annual production of about 550,000 humanoids and total robot DRAM demand of 21.5 petabytes. @zephyr_z9 put that at about 0.04% of roughly 48 exabytes of DRAM produced in 2026.

Musk’s Own Chip Cuts Weaken His Post Musk wrote that “Robot RAM needs will exceed everything else on Earth, as you need the robots to be on physical substates in order to shape atoms.” Musk added that “~100% of SI will be deep space compute,” which puts superintelligence memory off-planet.

On October 1, Musk said Tesla had cut memory on its AI5 chip in half, to 72GB, and on AI6 by a third, to 144GB. He called the cuts “the only way to get enough volume for Optimus production.” The company most eager to build humanoids is reducing memory per unit to reach volume, which shows that cost and supply limit how much memory each robot carries.

Micron’s Robot Upside Arrives Late in the Decade Micron’s chief executive, Sanjay Mehrotra, said on the September 30 earnings call that “humanoid robots will also require similar amounts of memory and storage as autonomous vehicles.” Highly autonomous vehicles typically carry more than 200GB of memory, well above Counterpoint’s per-robot figure for 2030.

Micron has begun sampling LPDDR6, a low-power DRAM, to physical AI customers. Low power draw matters in battery-powered machines. SK hynix is developing low-power memory for a major robotics computing platform, so Micron will have to compete for these orders.

Micron’s Automotive and Embedded segment, the business closest to robotics, produced $6.82 billion of fiscal fourth-quarter revenue, a small share of the total that robot orders would take years to move.

What Micron Investors Need to Watch Next Micron’s data center business supports the investment case, and robot demand is likely a long-dated addition on top of it. Micron forecast fiscal first-quarter 2027 revenue to $61.5 billion, and executives said more than 75% of shipments are committed for the year. The stock has fallen 16.49% over the past month.

The main risk is the memory cycle, because new clean rooms coming online in late ’28 and beyond could move pricing more than robot demand can offset.

Tesla offers less direct exposure to this theme because Optimus has not yet sold robots at commercial scale. Micron’s next report is estimated for December 16, though the company has not confirmed the date. If management names robot design wins at that report, the argument gains support. If it does not, Counterpoint Research’s 20-times robot DRAM forecast likely remains a 2030 story rather than a near-term revenue driver.

Contact [email protected] for any questions or corrections.
2026-10-27 13:35 1d ago
2026-10-27 05:16 1d ago
Ředitel Intuitive Surgical Barratt prodal 1 150 akcií
ISRG Intuitive Surgical
FMP Stock News 78
Original source text
Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) Director Craig Barratt sold 1,150 shares of the company’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the transaction, the director directly owned 1,150 shares of the company’s stock, valued at approximately $510,370. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Trading Down 0.1% NASDAQ:ISRG opened at $451.63 on Tuesday. The stock has a 50-day moving average price of $396.06 and a 200 day moving average price of $437.59. The stock has a market capitalization of $156.55 billion, a P/E ratio of 54.61, a P/E/G ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the previous year, the firm earned $2.40 EPS. The firm’s revenue was up 21.7% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analysts Set New Price Targets A number of brokerages have issued reports on ISRG. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. Barclays reiterated an “overweight” rating and issued a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Raymond James Financial restated an “outperform” rating and set a $480.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Stifel Nicolaus cut their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Mizuho reduced their target price on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $493.54. Get Our Latest Stock Report on ISRG

Key Intuitive Surgical News Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Analysts’ earnings estimates for ISRG are moving higher, suggesting improving expectations for the company’s near-term results and potentially supporting further gains. Earnings Estimates Moving Higher for Intuitive Surgical Positive Sentiment: Recent research continues to highlight Intuitive Surgical’s growth characteristics, including the potential for its robotic-surgery franchise to outperform the broader market over time. Intuitive Surgical Is an Incredible Growth Stock Neutral Sentiment: Intuitive Surgical remains a heavily watched stock, which may increase trading interest but does not by itself indicate a change in the company’s fundamentals. Intuitive Surgical Is a Trending Stock Neutral Sentiment: Reported short interest of zero shares and a zero-day days-to-cover ratio appears inconsistent with the description of a “significant increase,” making the data of limited value for gauging investor positioning. Negative Sentiment: Multiple insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold about $9.1 million of stock, while other executives and a director sold additional shares. The transactions were planned and Guthart retained more than 1.2 million shares, but the sales may still create modest sentiment pressure. Negative Sentiment: Investors remain sensitive to valuation risk: with a high earnings multiple, ISRG may need continued strong growth and upward estimate revisions to justify its price. Institutional Inflows and Outflows Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE increased its stake in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical during the second quarter valued at approximately $1,335,753,000. Amundi lifted its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its stake in shares of Intuitive Surgical by 3.7% in the 1st quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock valued at $757,489,000 after purchasing an additional 58,587 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

(Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Featured Articles Five stocks we like better than Intuitive Surgical Comfort Systems Earnings: AI Slowdown or More Growth Ahead? Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 13:35 1d ago
2026-10-27 08:22 1d ago
Amgen oznámí výsledky za třetí čtvrtletí 3. listopadu
AMGN Amgen
FMP Stock News 88
Original source text
SummaryOn November 3, Amgen Inc. will report its results for Q3.As a reminder, its Q2 non-GAAP EPS rose 25.8% quarter-on-quarter to $6.29, primarily due to the strong performance of biosimilars, Blincyto, and Repatha.On October 24, Amgen released promising results from the DeLLphi-305 study evaluating Imdelltra+Imfinzi in the treatment of extensive-stage small-cell lung cancer.Meanwhile, Amgen yields about 2.3% and trades at 12.9x forward EV/EBITDA.In this article, I'll explain why Amgen offers an attractive risk/reward profile. Daniel Balakov/E+ via Getty Images

Amgen Inc. (AMGN) stock was up almost 18.4% since it reached the +1σ band formed from the VWAP, $376, on September 16th.

I believe this growth reflects its R&D success.

In particular, on October 24th, Amgen

3.66K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-10-27 13:33 1d ago
2026-10-27 07:45 1d ago
Medtronic zvýšil dividendu na 0,72 USD
MDT Medtronic
FMP Stock News 95
Original source text
Medtronic just extended a nearly half-century dividend streak, but its raise barely outpaces inflation while rivals like Abbott and J&J grow payouts far faster. Whether explosive growth in cardiac ablation can close that gap is the real question for income…

Medtronic (NYSE:MDT | MDT Price Prediction) raised its quarterly dividend to $0.72 per share from $0.71, extending its run to 49 consecutive years of increases. The raise works out to about 1.4%. It lands as the company posts its strongest growth in years and finishes splitting off its diabetes unit. For retirees, the question is whether a 2.95% yield earns a spot in an income portfolio.

A Small Raise on a Long Streak Medtronic declared the higher payout on June 3, 2026, and kept it at $0.72 for the October 16, 2026 payment. That sets the forward annual dividend at $2.88. The pattern is steady but slow: $0.68 in 2022, $0.69 in 2023, $0.70 in 2024.

Peers raise faster. Abbott Laboratories (NYSE:ABT) raised its quarterly payout to $0.63 from $0.59, roughly 6.8%, and has increased it for 54 consecutive years. Johnson & Johnson (NYSE:JNJ) lifted its dividend 3.1% to $1.34 and has a 64-year run. Medtronic is nearing the 50-year Dividend King threshold.

Cash Flow Covers the Check With Room to Spare The payout ratio is the share of profit a company hands to shareholders. Medtronic raised its fiscal 2027 adjusted EPS guidance to $5.94-$6.00, so the $2.88 dividend takes about 48% of expected earnings. In the first quarter, free cash flow (cash left after capital spending) reached $1.29 billion, up 120.89%, against $921 million in dividends paid. Management pointed to a strong balance sheet and a 70% cash-conversion rate, with a path to 80%.

Cardiac Ablation Is Powering the Growth Story First-quarter revenue rose 13.7% to $9.76 billion, and adjusted EPS of $1.45 exceeded the $1.3874 consensus. An extra fiscal week added about $570 million. Cardiac Ablation Solutions grew 88% on the Affera system and Sphere-9 catheter. CEO Geoff Martha said:

“We’re only at the beginning for CAS. With a differentiated platform, a growing installed base, expanding indications and a strong innovation pipeline, we are well positioned to treat more patients.”

J&J’s electrophysiology sales grew just 4.4% in its latest quarter. Martha framed the momentum as broad:

“What gives us confidence is not simply the strength of the quarter, but importantly, the breadth of performance across our businesses.”

MiniMed Split and Margin Pressure Bring Risks Medtronic completed the separation of MiniMed Group (NASDAQ:MMED) on October 15, 2026. Management expected the exit to lift operating margin about 100 basis points while cutting revenue growth about 20 basis points. Current guidance assumed Diabetes stayed in through fiscal year-end, so expect revisions at the December 10 and 11th investor day. Tariffs cost roughly $185 million in fiscal 2026, and shares remain down 10.09% over five years.

Verdict: A Secure Dividend That Grows Slowly At $94.33, Medtronic trades at 14x forward earnings, with a beta of 0.567 indicating below-market volatility. Analysts’ average target is $104.62. The dividend looks well covered and durable, which suits retirees seeking stability. It trails Abbott and J&J, so the stronger case rests on ablation-driven earnings growth that could support bigger increases ahead.

Contact [email protected] for any questions or corrections.
2026-10-27 13:32 1d ago
2026-10-27 09:00 1d ago
Broadcom vydal 89 záplat pro zranitelnosti v TrueSource Spring Enterprise
AVGO Broadcom
FMP Stock News 78
Original source text
PALO ALTO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops, and supplies semiconductor and infrastructure software solutions, today shipped fixes for 89 novel vulnerabilities in TrueSource Spring Enterprise to its critical infrastructure customers and others who qualify for early access, ahead of public disclosure. This brings the total number of vulnerabilities fixed across TrueSource offerings to 408.

Patches only secure an environment once deployed. To close that gap, Spring Enterprise adds TrueSource Hub to help enterprises assess application exposure, prioritize critical fixes, and track status. Additionally, build plugins for Application Advisor automate patching within existing Maven or Gradle workflows, generating update pull requests to streamline merging approved fixes.

A sustained investment in open source security

Building on its June 2026 open source commitment, Broadcom uses Frontier AI scanning and advanced research to find and fix vulnerabilities. TrueSource Spring Enterprise delivers simultaneous fixes across all supported versions, giving legacy releases immediate access, while providing security-only patches for current versions to speed deployment. Detailed vulnerability information will be published when fixes reach the community and CVEs are issued.

Scale & Impact: Reaching a massive footprint of downloads of Spring and Reactor libraries in 2026, Broadcom engineers fixed 406 new vulnerabilities, delivered over 1,090 fixes (including 798 backports), reviewed 2,600+ reports, and filtered out 3,000+ false alarms.

Key High/Critical Broadcom Fixes Earlier This Year:

Spring (June): Fixed a remote code execution vulnerability (CVE-2026-41855, CVSS 8.1) across four supported lines simultaneously.Netty Dependency (June): Discovered a DNS redirection vulnerability (CVE-2026-47691, CVSS 10.0) and addressed with the community maintainers and fixed for all supported Spring versions.RabbitMQ (July): Fixed a credential forgery vulnerability (CVE-2026-67404, CVSS 9.2) across four supported lines at once. “Security isn’t a one-time initiative; it’s an ongoing commitment. In June, we pledged to identify and resolve Spring vulnerabilities faster than ever, and today’s release demonstrates our continued momentum,” said Purnima Padmanabhan, general manager, Tanzu Division, Broadcom. “Our customers receive critical fixes early in a deployable format, with complete visibility into where patches belong and confirmation when they land. Crucially, fixes are contributed back to the open source community—because open source remains resilient only when businesses actively invest in ecosystem health.”

See it, prioritize it, fix it, prove it

Most enterprises know they run open source. Few can say exactly which applications run which versions, which are out of support, and which need a fix published this morning. TrueSource Spring Enterprise closes that gap with four capabilities that work together:

Assess every repository. TrueSource Hub connects to an organization’s code repositories and shows the security state of the open source components every application depends on, across Java, Python, and JavaScript libraries, container images, and data services, along with its patch status, in a live view rather than a one-time audit.Prioritize the fixes that matter. When Broadcom publishes a fix, Hub shows which applications need it and how exposed they are, so security and engineering leaders can direct effort to the applications that carry the most risk. TrueSource works with the vulnerability scanners that teams already use. Snyk, for example, is actively partnering with Broadcom so that customers can recognize Broadcom-patched Spring versions as fixed, with the goal of reducing unnecessary alerts and keeping teams from chasing alerts for already-resolved vulnerabilities.Apply patches in the build. For Spring applications, Spring Application Advisor plugins integrate directly into existing Maven and Gradle builds. Fixes and version upgrades arrive as reviewable pull requests built on deterministic recipes verified by TrueSource engineers. Additionally, the new integration with JFrog Zero-Touch Remediation delivers instant protection. By automatically delivering verified, backward-compatible TrueSource fixes to builds, security teams can stop waiting on manual pull requests and dependency overrides - keeping software secure with zero friction.Prove it through pipeline audits. Every build records its source and the libraries it contains and reports that to TrueSource, so security leaders can show their boards and leadership exactly which libraries shipped and where each fix was applied. The TrueSource portfolio

TrueSource by Broadcom is Broadcom’s portfolio of enterprise open source software, verified by engineers and delivered from one trusted source. It has three offerings:

TrueSource Spring Enterprise for the Spring framework Broadcom maintains, with CVE-only patches, the security fix and nothing else, delivered for every supported version at the same time so teams can apply them without an upgrade, plus the tooling announced today.TrueSource Trusted Artifacts for verified open source libraries in Java, Python, and JavaScript, and the Secure Images catalog of container images, covering the middleware, runtimes, and backing services applications depend on.TrueSource Data Services for the data engines applications rely on: PostgreSQL, MySQL, Valkey, and RabbitMQ, with self-service provisioning, fleet management across environments, and enterprise support for the engines themselves, including prescribed high availability and disaster recovery. Availability

TrueSource Spring Enterprise, featuring TrueSource Hub and build plugins, is generally available today. Its 87 fixes are accessible immediately to early-access and critical infrastructure customers, with public CVE release to follow. TrueSource Spring Enterprise, Trusted Artifacts, and Data Services are offered via tiered site licensing. Learn more at https://www.broadcom.com/products/software/truesource.

About Broadcom

Broadcom Inc. (NASDAQ: AVGO) is a technology leader that designs, develops, and supplies semiconductors and infrastructure software for global organizations’ complex, mission-critical needs. Broadcom combines long-term R&D investment with superb execution to deliver the best technology, at scale. Broadcom is a Delaware corporation headquartered in Palo Alto, CA. For more information, visit www.broadcom.com.

Broadcom and the pulse logo are among the trademarks of Broadcom. Postgres and PostgreSQL are registered trademarks of the PostgreSQL Community Association of Canada. MySQL is a registered trademark of Oracle Corporation. Valkey is a trademark of The Linux Foundation. All other trademarks are the property of their respective owners. Broadcom is not affiliated with, endorsed by, or sponsored by any of the foregoing organizations.

Media contact

John D’Avolio

Tanzu Division, Broadcom

+1.503.308.3096

[email protected]
2026-10-27 13:32 1d ago
2026-10-27 09:23 1d ago
DA Davidson zvýšila doporučení pro společnost Broadcom na „koupit“
AVGO Broadcom
FMP Stock News 84
Original source text
Anthropic’s newly public IPO filing has made Broadcom (NASDAQ:AVGO | AVGO Price Prediction) the chip name most tightly bound to the AI lab’s compute expansion, and a fresh analyst upgrade now puts a higher price target on that link. Broadcom…

Anthropic’s newly public IPO filing has made Broadcom (NASDAQ:AVGO | AVGO Price Prediction) the chip name most tightly bound to the AI lab’s compute expansion, and a fresh analyst upgrade now puts a higher price target on that link. Broadcom stock is at $339.90, up 3% in early trade, a move that adds new weight to its custom chip business. The upgrade and a stronger semiconductor group are both feeding the gain.

Meanwhile, NVIDIA (NASDAQ:NVDA) shares are at $218.41, up 1%, a smaller advance that leaves Broadcom stock out in front. Chip stocks are broadly stronger, with the iShares Semiconductor ETF (NASDAQ:SOXX) up 2%. Large-cap tech is trailing that pace, as the Invesco QQQ Trust (NASDAQ:QQQ) is up 0.6%.

DA Davidson Upgrade Puts a Price on Anthropic Ties
DA Davidson upgraded Broadcom stock to Buy from Neutral and raised its price target to $400, arguing that Anthropic’s IPO filing signals the AI spending cycle still has room to run. Under that thesis, Anthropic raises capital first and OpenAI follows, giving Broadcom the funding pipeline it needs to meet its growth expectations. Anthropic’s IPO registration, made public a day before the upgrade, describes Broadcom as both a supplier and a lessor of its AI computing equipment under a non-cancelable lease.

Those leases run five years and give Anthropic access to compute capacity built on tensor processing units (TPUs), with a portion online in 2026 and more slated to start in 2027. In April, Anthropic also deposited cash into a restricted account for Broadcom’s benefit to secure compute capacity. Such terms ground the upgrade in signed, collateralized commitments that run well beyond a single quarter.

Broadcom’s Concentrated Model Sets It Apart From NVIDIA and AMD
Broadcom designs custom AI accelerators for a small number of large customers alongside its networking chips, so its growth turns on a few buyers’ spending plans. NVIDIA sells general-purpose AI processors and systems to a broad customer base, and Advanced Micro Devices (NASDAQ:AMD) offers chips and AI accelerators across data center and PC markets. Spreading revenue across many buyers gives NVIDIA and AMD a buffer when any single customer slows its spending. AMD shares are up 2% to $544.

Broadcom’s recent results show how far that concentration has already carried the company. In Q3 FY2026, Broadcom’s AI semiconductor revenue reached $16.7 billion, up 221% year over year, and its Q4 FY2026 outlook calls for $21.7 billion. On the September earnings call, the company put Anthropic on track to become its largest custom accelerator customer in 2027.

However, so much of Broadcom’s growth rides on customers whose funding isn’t yet secured, as Anthropic’s lease obligations can accelerate on certain unresolved payment or performance defaults, which ties the arrangement to the lab’s ability to stay current. For NVIDIA, a broad customer base limits its dependence on any single lab’s capital raise, though that same breadth leaves it with less direct leverage to Anthropic’s listing.

Broadcom’s Upside Hinges on Anthropic’s Listing
Broadcom now faces the question of whether Anthropic completes its IPO and converts the filing into fresh capital. OpenAI’s fundraising stands behind that step, since the upgrade’s thesis counts on both companies raising money.

Anyone sizing up their exposure should adjust their holdings carefully given how much of Broadcom’s growth rides on a few customers whose funding is still being raised. Measuring a position with that concentration in mind, rather than on the upgrade alone, can mitigate the risk of slower-than-anticipated AI spending.

Contact [email protected] for any questions or corrections.
2026-10-27 13:29 1d ago
2026-10-27 07:21 1d ago
S&P Global zveřejnila výsledky za třetí čtvrtletí
SPGI S&P Global
FMP Stock News 75
Original source text
, /PRNewswire/ -- S&P Global (NYSE: SPGI) today reported third quarter results. The Company's earnings release and supplemental materials are available at http://investor.spglobal.com/Quarterly-Earnings. 

Supplemental Information/Conference Call/Webcast Details: The Company's senior management will review the third quarter 2026 earnings results on a conference call scheduled for today, October 27, at 8:30 a.m. EDT. Additional information presented on the conference call, and the Company's supplemental slide content may be found on the Company's Investor Relations Website at http://investor.spglobal.com/Quarterly-Earnings. 

The Webcast will be available live and in replay at http://investor.spglobal.com/Quarterly-Earnings. 

About S&P Global
S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive in a rapidly changing global landscape.

From helping our customers assess new investments across the capital and commodities markets to navigating the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world's leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today. Learn more at www.spglobal.com.

Investor Relations: http://investor.spglobal.com 

Contact:

Investor Relations:
Mark Grant
Senior Vice President, Investor Relations and Treasurer
Tel: +1 (347) 640-1521
[email protected] 

Media:
Christina Twomey
Chief Communications Officer
Tel: +1 (646) 407-3001
[email protected] 

SOURCE S&P Global
2026-10-27 13:28 1d ago
2026-10-27 08:13 1d ago
Edible Garden získala sváteční program dodávek bylinek pro Kroger
KR Kroger Company
FMP Stock News 84
Original source text
BELVIDERE, NJ, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform, today announced that it has secured a holiday fresh herb program with Kroger, one of the nation's largest grocery retailers, for the upcoming Thanksgiving through New Year holiday season. The program represents another step in Edible Garden's continued expansion with major national retailers, further strengthening its retail presence and supporting its strategy of capturing a greater share of the fresh herb market.

The Thanksgiving through New Year period is one of the most important selling seasons for fresh herbs, as holiday cooking drives increased demand for popular culinary ingredients such as rosemary, sage, thyme, parsley, and poultry-blend herbs. The Kroger program, together with previously announced holiday initiatives with Walmart and Target, positions Edible Garden to capitalize on increased seasonal demand, drive additional sales, and further expand its presence among the nation's leading retailers.

“This holiday program with Kroger represents another significant commercial win for Edible Garden and an important milestone for our Edible Garden Heartland operation in Grand Rapids, Michigan,” said Jim Kras, Chief Executive Officer of Edible Garden. “Our Heartland facility was strategically established to serve leading retailers throughout the Midwest, and this program demonstrates how our investment in regional production and distribution capabilities is translating into meaningful commercial opportunities. Kroger's decision to include Edible Garden in its holiday program reinforces the confidence major retailers are placing in our ability to deliver fresh, high-quality herbs reliably and at scale during periods of peak demand. Beyond the immediate revenue opportunity, we believe this program will increase utilization of our Heartland facility, strengthen our presence in the Midwest, and advance our Zero-Waste Inspired® mission by bringing locally grown products closer to consumers, while providing a foundation for continued growth.”

Edible Garden plans to support the Kroger holiday program through its established growing and distribution network, utilizing its proprietary GreenThumb 2.0 technology to align production with seasonal demand. By leveraging its existing infrastructure, the Company aims to efficiently manage increased order volumes, capitalize on new sales opportunities, and strengthen its position in the fresh produce market.

ABOUT EDIBLE GARDEN®

Edible Garden AG Incorporated is a leader in controlled environment agriculture (CEA), delivering organic, better-for-you, sustainable produce and products through its Zero-Waste Inspired® next-generation farming model. Available in over 6,000 retail locations across the United States, Caribbean, and South America, Edible Garden is at the forefront of the CEA and sustainability technology movement, distinguished by its advanced safety-in-farming protocols, sustainable packaging, patented GreenThumb software, and innovative Self-Watering in-store displays. The Company operates state-of-the-art, vertically integrated greenhouses and processing facilities, including Edible Garden Heartland in Grand Rapids, Michigan; Edible Garden Prairie Hills in Webster City, Iowa; and its headquarters at Edible Garden Belvidere in New Jersey. It also partners with a network of contract growers strategically located near major U.S. markets to ensure freshness and reduce environmental impact. The Company is also expanding its Prairie Hills facility in Webster City, Iowa, into a dedicated ready-to-drink (RTD) clean nutrition manufacturing hub, supporting its Farm-to-Formula® strategy and its transformation into higher-margin, shelf-stable nutrition categories.

Edible Garden’s proprietary GreenThumb 2.0 software—protected by U.S. Patents US 11,158,006 B1, US 11,410,249 B2, and US 11,830,088 B2—optimizes vertical and traditional greenhouse growing conditions while aiming to reduce food miles. Its patented Self-Watering display (U.S. Patent No. D1,010,365) is designed to extend plant shelf life and elevate in-store presentation. In addition to its core CEA operations, Edible Garden owns three patents in advanced aquaculture technologies: a closed-loop shrimp farming system (US 6,615,767 B1), a modular recirculating aquaculture setup with automated water treatment and feeding (US 10,163,199 B2), and a sensor-driven ammonia control method utilizing electrolytic chlorine generation (US 11,297,809 B1).

The Company has been recognized as a FoodTech 500 firm by Forward Fooding, is a multi-year participant in Walmart’s Project Gigaton and a Giga Guru designee and has received NRG’s Excellence in Energy Award for its commitment to measurable environmental performance and energy stewardship. Edible Garden also develops and markets a growing line of nutrition and specialty food products, including Vitamin Way® and Vitamin Whey®—plant and whey protein powders—and Kick. Sports Nutrition, a premium performance line for health-conscious athletes seeking cleaner, better-for-you options. The Company’s offerings further include fresh, sustainable condiments such as Pulp fermented gourmet and chili-based sauces, as well as Pickle Party, a collection of fermented fresh pickles and krauts.

Learn more at https://ediblegardenag.com.
For Pulp products, visit https://www.pulpflavors.com.
For Vitamin Whey® products, visit https://vitaminwhey.com.
For Kick. Sports Nutrition products, visit https://kicksportsnutrition.net/.
Watch the Company’s latest corporate video here.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believe,” “expect,” “intend,” “plan,” “expand,” “advance,” “designed to,” “opportunity,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. These statements include, without limitation, statements regarding the Company’s holiday fresh herb program with Kroger, the expected benefits of the Company’s recent Kroger distribution center awards, the Company’s ability to expand its presence and capture additional market share in its key markets, the Company’s available capacity and ability to service additional retail volume, the Company’s ability to deepen its relationship with Kroger and other major retailers, the development of the Company’s ready-to-drink manufacturing facility in Webster City, Iowa, and the Company’s Farm-to-Formula® strategy. There can be no assurance that the holiday program or the Company’s distribution center awards will result in the anticipated volume, revenue or market share gains. Forward-looking statements are based on the Company’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including those described in the “Risk Factors” section and other sections of the Company’s reports filed with the Securities and Exchange Commission. All forward-looking statements speak only as of the date on which they are made, and the Company undertakes no duty to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contacts:
Crescendo Communications, LLC
212-671-1020
[email protected]
2026-10-27 13:27 1d ago
2026-10-27 08:11 1d ago
Ares Capital nenaplnila odhady zisku na akcii ani tržeb
ARCC Ares Capital
FMP Stock News 88
Original source text
Ares Capital (ARCC - Free Report) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.5 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -4.17%. A quarter ago, it was expected that this private equity firm would post earnings of $0.47 per share when it actually produced earnings of $0.47, delivering no surprise.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

Ares Capital, which belongs to the Zacks Financial - SBIC & Commercial Industry industry, posted revenues of $763 million for the quarter ended September 2026, missing the Zacks Consensus Estimate by 2.2%. This compares to year-ago revenues of $782 million. The company has not been able to beat consensus revenue estimates over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Ares Capital shares have lost about 8% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Ares Capital?While Ares Capital has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Ares Capital was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.49 on $793.81 million in revenues for the coming quarter and $1.91 on $3.1 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - SBIC & Commercial Industry is currently in the top 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Goldman Sachs BDC (GSBD - Free Report) , is yet to report results for the quarter ended September 2026. The results are expected to be released on November 5.

This specialty finance company is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -7.5%. The consensus EPS estimate for the quarter has been revised 2.6% higher over the last 30 days to the current level.

Goldman Sachs BDC's revenues are expected to be $86.16 million, down 5.9% from the year-ago quarter.
2026-10-27 13:26 1d ago
2026-10-27 07:00 1d ago
Sherwin-Williams zvýšil tržby, čistý zisk klesl
SHW Sherwin-Williams
FMP Stock News 99
Original source text
, /PRNewswire/ -- The Sherwin-Williams Company (NYSE: SHW) announced its financial results for the third quarter ended September 30, 2026. All comparisons are to the third quarter of the prior year, unless otherwise noted.

SUMMARY

The Sherwin-Williams Company Reports 2026 Third Quarter Financial Results Consolidated Net sales increased 7.9% to $6.86 billion in the quarterNet sales from stores in the Paint Stores Group open more than twelve calendar months increased 3.9% in the quarterDiluted net income per share increased 0.9% to $3.38 per share in the quarter compared to $3.35 per share in the third quarter of 2025Adjusted diluted net income per share increased 1.1% to $3.63 per share in the quarter compared to $3.59 per share in the third quarter of 2025Net income decreased 1.5% in the quarter to $821.0 million, or 12.0% of Net salesEarnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) in the quarter increased 3.4% to $1.39 billion, or 20.3% of Net salesAdjusted EBITDA in the quarter increased 3.3% to $1.40 billion, or 20.5% of Net salesRevising full year 2026 diluted net income per share guidance in the range of $10.92 to $11.22 per share, including Valspar acquisition-related amortization expense of $0.82 per share and severance and other restructuring expenses of $0.11 per shareNarrowing full year 2026 adjusted diluted net income per share guidance in the range of $11.85 to $12.15 per share CEO REMARKS

"Sherwin-Williams third quarter performance demonstrated the resilience of our Company and the strength of our strategy in a challenging demand environment. Despite muted underlying market volumes, we continued to win new customers, increase share-of-wallet and deliver sales growth across all three reportable segments, at or above our guidance, supported by the differentiated value and productivity our solutions deliver to customers. At the same time, we took disciplined pricing and cost actions to address inflationary pressures, thoughtfully timed with our customers in mind," said Chair, President and Chief Executive Officer, Heidi G. Petz. "Gross margin was primarily impacted in the quarter by higher raw material and supply chain related costs and by mix, including dilution from Suvinil and higher growth in lower margin reportable segments. Excluding the dilutive impact of the Suvinil acquisition, our year-to-date gross margin is flat compared to the prior year. SG&A as a percent of sales decreased in the quarter, as we continue to identify and implement efficiencies throughout our Company. Adjusted EBITDA and adjusted diluted earnings per share both grew over last year's third quarter levels. We returned $749.0 million to shareholders in the quarter through dividends and share repurchases. Our team remains focused on serving our customers and controlling what we can control to continue top and bottom-line growth."

THIRD QUARTER CONSOLIDATED RESULTS
(in millions, except per share data)

Three Months Ended September 30,

2026

2025

$ Change

% Change

Net sales

$       6,860.0

$       6,358.2

$          501.8

7.9 %

Income before income taxes

$       1,063.5

$       1,060.5

$             3.0

0.3 %

Percent to Net sales

15.5 %

16.7 %

Net income per share - diluted

$           3.38

$           3.35

$            0.03

0.9 %

Adjusted net income per share - diluted

$           3.63

$           3.59

$            0.04

1.1 %

Consolidated Net sales increased primarily due to higher Net sales in all reportable segments, inclusive of the October 2025 acquisition of Suvinil, and selling price increases, which impacted Net sales by a mid-single digit percentage.

Income before income taxes increased slightly due to an increase in Net sales, partially offset by higher raw material and supply chain related costs, incremental selling, general and administrative (SG&A) expenses associated with Suvinil and higher costs in the Administrative function related to additional interest expense attributable to an increase in debt.

Diluted net income per share included a charge of $0.21 and $0.20 per share for Valspar acquisition-related amortization expense in the third quarter of 2026 and 2025, respectively. Diluted net income per share also included a charge of $0.04 per share related to severance and other restructuring expenses in both the third quarter of 2026 and 2025.

THIRD QUARTER SEGMENT RESULTS
(in millions)Paint Stores Group (PSG)

Three Months Ended September 30,

2026

2025

$ Change

% Change

Net sales

$        4,015.8

$        3,836.8

$          179.0

4.7 %

Same-store sales (1)

3.9 %

3.6 %

Segment profit

$          974.3

$          954.3

$            20.0

2.1 %

Reported segment margin

24.3 %

24.9 %

(1)

Same-store sales represents Net sales from stores open more than twelve calendar months.

Net sales in PSG increased primarily due to selling price increases, which impacted Net sales by a mid-single digit percentage, as well as low-single digit percentage sales volume growth. Net sales increased in all professional customer end markets, led by a double digit percentage increase in protective and marine, a high-single digit percentage increase in commercial and a mid-single digit percentage increase in residential repaint. Segment profit increased primarily due to higher Net sales, partially offset by higher raw material and supply chain related costs and increased costs to support higher sales, including investments in additional sales reps and stores.

Consumer Brands Group (CBG)

Three Months Ended September 30,

2026

2025

$ Change

% Change

Net sales

$          937.4

$          770.1

$          167.3

21.7 %

Segment profit

$          146.2

$          157.3

$          (11.1)

(7.1) %

Reported segment margin

15.6 %

20.4 %

Adjusted segment profit (1)

$          171.4

$          179.3

$            (7.9)

(4.4) %

Adjusted segment margin

18.3 %

23.3 %

(1)

Adjusted segment profit equals Segment profit excluding the impact of Valspar acquisition-related amortization expense and severance and other restructuring expenses. In CBG, Valspar acquisition-related amortization expense was $15.5 million and $15.6 million in the third quarter of 2026 and 2025, respectively, and severance and other restructuring expenses were $9.7 million and $6.4 million in the third quarter of 2026 and 2025, respectively.

Net sales in CBG increased primarily as a result of the acquisition of Suvinil, favorable foreign currency translation and a positive shift in mix, partially offset by soft demand in North America. Segment profit decreased primarily due to higher raw material and supply chain costs, incremental SG&A expenses associated with the Suvinil acquisition and unfavorable foreign currency transaction gains and losses, partially offset by higher Net sales. Adjusted segment profit decreased for these same reasons.

Valspar acquisition-related amortization expense reduced Segment profit as a percent of Net sales by 170 and 200 basis points in the third quarter of 2026 and 2025, respectively. Severance and other restructuring expenses reduced Segment profit as a percent of Net sales by 100 and 90 basis points in the third quarter of 2026 and 2025, respectively.

Performance Coatings Group (PCG)

Three Months Ended September 30,

2026

2025

$ Change

% Change

Net sales

$        1,903.3

$        1,750.0

$          153.3

8.8 %

Segment profit

$          255.2

$          240.3

$            14.9

6.2 %

Reported segment margin

13.4 %

13.7 %

Adjusted segment profit (1)

$          308.7

$          294.9

$            13.8

4.7 %

Adjusted segment margin

16.2 %

16.9 %

(1)

Adjusted segment profit equals Segment profit excluding the impact of Valspar acquisition-related amortization expense and severance and other restructuring expenses. In PCG, Valspar acquisition-related amortization expense was $49.8 million and $49.5 million in the third quarter of 2026 and 2025, respectively, and severance and other restructuring expenses were $3.7 million and $5.1 million in the third quarter of 2026 and 2025, respectively.

Net sales in PCG increased primarily due to selling price increases, which impacted Net sales by a mid-single digit percentage, and low-single digit percentage sales volume growth. Net sales increased in all businesses, led by General Industrial, Packaging and Coil, which each increased by a double digit percentage, and Industrial Wood and Automotive Refinish, which each increased by a low-single digit percentage. Segment profit increased primarily due to higher Net sales, partially offset by higher raw material and supply chain related costs and an increase in employee-related costs to support higher sales. Adjusted segment profit increased for these same reasons, including a slight decrease in the expenses associated with targeted restructuring actions in the third quarter of 2026.

Valspar acquisition-related amortization expense reduced Segment profit as a percent of Net sales by 260 and 290 basis points in the third quarter of 2026 and 2025, respectively. Severance and other restructuring expenses reduced Segment profit as a percent of Net sales by 20 and 30 basis points in the third quarter of 2026 and 2025, respectively.

LIQUIDITY AND CASH FLOW

The Company generated $2.59 billion in Net operating cash and returned cash of $2.98 billion to our shareholders in the form of dividends and repurchases of 7.1 million shares of its common stock during the first nine months of 2026. At September 30, 2026, the Company had remaining authorization to purchase 22.5 million shares of its common stock through open market purchases.

2026 GUIDANCE

Fourth Quarter

Full Year

2026

2026

Net sales

Up mid-single digit %

Up mid to high-single digit %

Effective tax rate

Low twenty percent

Diluted net income per share

$10.92

-

$11.22

Adjusted diluted net income per share (1)

$11.85

-

$12.15

(1)

Excludes $0.82 per share of Valspar acquisition-related amortization expense and $0.11 per share of severance and other restructuring expenses incurred through September 30, 2026.

"Customer sentiment and the leading indicators we track point to muted demand over the remainder of the year and into 2027. As we navigate this environment, our focus remains clear: win in the marketplace, serve our customers, offset inflation, reduce costs and continue to deliver profitable growth and shareholder value," said Ms. Petz.

"Against this backdrop, we expect fourth quarter 2026 consolidated Net sales to increase by a mid-single digit percentage compared to the fourth quarter of 2025, resulting in us maintaining our full year 2026 sales guidance where consolidated Net sales are expected to be up a mid to high-single digit percentage compared to full year 2025. Diluted net income per share is expected to be in the range of $10.92 to $11.22 per share, including acquisition-related amortization expense of $0.82 per share and severance and other restructuring expenses of $0.11 per share, compared to $10.26 per share in 2025. Full year 2026 adjusted diluted net income per share is expected to be in the range of $11.85 to $12.15 per share compared to $11.43 per share in 2025. We remain highly confident in our ability to deliver through current conditions while building an even stronger Sherwin-Williams for the future."

CONFERENCE CALL INFORMATION

The Company will host a conference call to discuss its financial results for the third quarter, and its outlook for the fourth quarter and full year 2026, at 10:00 a.m. EDT on Tuesday, October 27, 2026. Heidi G. Petz, Sherwin-Williams' Chair, President and Chief Executive Officer, along with other senior executives, will participate on the call.

The conference call will be webcast simultaneously in listen only mode. To listen to the webcast on the Sherwin-Williams website, click on https://investors.sherwin-williams.com/financials/quarterly-results/, then click on the webcast icon following the reference to the Q3 webcast. An archived replay of the webcast will be available at https://investors.sherwin-williams.com/financials/quarterly-results/ beginning approximately two hours after the call ends.

ABOUT THE SHERWIN-WILLIAMS COMPANY

Founded in 1866, The Sherwin-Williams Company is a global leader in the manufacture, development, distribution, and sale of paint, coatings and related products to professional, industrial, commercial and retail customers. The Company manufactures products under well-known brands such as Sherwin-Williams®, Valspar®, HGTV HOME® by Sherwin-Williams, Dutch Boy®, Krylon®, Minwax®, Thompson's® WaterSeal®, Cabot®, Suvinil® and many more. With global headquarters in Cleveland, Ohio, Sherwin-Williams® branded products are sold exclusively through a chain of more than 5,400 Company-operated stores and branches, while the Company's other brands are sold through leading mass merchandisers, home centers, independent paint dealers, hardware stores, automotive retailers and industrial distributors. The Sherwin-Williams Performance Coatings Group supplies a broad range of highly-engineered solutions for the construction, industrial, packaging and transportation markets in more than 120 countries around the world. Sherwin-Williams shares are traded on the New York Stock Exchange (symbol: SHW). For more information, visit www.sherwin.com.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws. These forward-looking statements are based upon management's current expectations, predictions, estimates, assumptions and beliefs concerning future events and conditions and may relate to, among other things, anticipated future performance (including sales and earnings), expected growth, and future business plans. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as "anticipate," "aspire," "believe," "could," "estimate," "expect," "goal," "intend," "may," "plan," "potential," "project," "seek," "should," "strive," "target," "will," or "would" or the negative thereof or comparable terminology.

Readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside our control, that could cause actual results to differ materially from such statements and from our historical results, performance and experience. These risks, uncertainties and other factors include such things as: general business and economic conditions in the United States and worldwide; inflation rates, interest rates, unemployment rates, labor costs, healthcare costs, recessionary conditions, geopolitical conditions, terrorist activity, armed conflicts and wars, public health crises, pandemics, outbreaks of disease and supply chain disruptions; shifts in consumer behavior driven by economic downturns in cyclical segments of the economy; shortages and increases in the cost of raw materials and energy; catastrophic events, adverse weather conditions and natural disasters (including those that may be related to climate change); disruptions to our information technology systems, including due to digitization efforts or cybersecurity incidents; our ability to attract, retain, develop and progress a qualified global workforce; the loss of any of our largest customers; increased competition or failure to keep pace with developments in key competitive areas of our business; our ability to successfully integrate past and future acquisitions, into our existing operations; risks and uncertainties associated with our expansion into and our operations in South America, Asia, Europe and other foreign markets; policy changes affecting international trade, including import/export restrictions and tariffs; our ability to achieve our strategies or expectations relating to sustainability considerations, including as a result of evolving legal, regulatory and other standards, processes and assumptions, the pace of scientific and technological developments, increased costs, the availability of requisite suppliers, energy sources, or financing and changes in carbon markets and carbon accounting rules; damage to our business, reputation, image or brands due to negative publicity; the infringement or loss of our intellectual property rights or the theft or unauthorized use of our trade secrets or other confidential business information; a weakening of global credit markets or changes to our credit ratings; our ability to generate cash to service our indebtedness; fluctuations in foreign currency exchange rates and changing monetary policies; our ability to comply with a variety of complex U.S. and non-U.S. laws, rules and regulations; increases in tax rates, or changes in tax laws or regulations; our ability to comply with numerous, complex and increasingly stringent domestic and foreign health, safety and environmental laws, regulations and requirements; our liability related to environmental investigation and remediation activities at some of our currently- and formerly-owned sites; the nature, cost, quantity and outcome of pending and future litigation, including lead pigment and lead-based paint litigation; and the other risk factors discussed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 and our other reports filed with the SEC.

Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the above list should not be considered a complete list. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as otherwise required by law.

INVESTOR RELATIONS CONTACT:

Jim Jaye                                                                              

Senior Vice President, Investor Relations & Corporate Communications
Sherwin-Williams                                
Direct: 216.515.8682
[email protected]

MEDIA CONTACT:

Julie Young

Vice President, Global Corporate Communications
Sherwin-Williams
Direct: 216.515.8849
[email protected]

The Sherwin-Williams Company and Subsidiaries

Statements of Consolidated Income (Unaudited)

(in millions, except per share data)

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net sales

$       6,860.0

$       6,358.2

$     19,316.2

$     17,978.4

Cost of goods sold

3,582.8

3,232.7

9,920.5

9,175.5

Gross profit

3,277.2

3,125.5

9,395.7

8,802.9

Percent to Net sales

47.8 %

49.2 %

48.6 %

49.0 %

Selling, general and administrative expenses

2,069.1

1,952.8

6,142.4

5,758.2

Percent to Net sales

30.2 %

30.7 %

31.8 %

32.0 %

Other general expense (income) - net

5.2

(4.7)

14.9

10.5

Interest expense

139.3

117.2

406.8

333.4

Interest income

(5.9)

(2.6)

(14.1)

(8.3)

Other expense (income) - net

6.0

2.3

(10.1)

9.9

Income before income taxes

1,063.5

1,060.5

2,855.8

2,699.2

Income taxes

242.5

227.4

656.5

607.5

Net income

$         821.0

$         833.1

$       2,199.3

$       2,091.7

Net income per common share:

Basic

$          3.41

$          3.38

$          9.03

$          8.43

Diluted

$          3.38

$          3.35

$          8.95

$          8.34

Weighted average shares outstanding:

Basic

240.7

246.2

243.5

248.0

Diluted

242.8

249.0

245.7

250.9

The Sherwin-Williams Company and Subsidiaries

Business Segments (Unaudited)

(millions of dollars)

2026

2025

Net

Segment

Net

Segment

Sales

Profit (Loss)

Sales

Profit (Loss)

Three Months Ended September 30:

Paint Stores Group

$       4,015.8

$          974.3

$        3,836.8

$          954.3

Consumer Brands Group

937.4

146.2

770.1

157.3

Performance Coatings Group

1,903.3

255.2

1,750.0

240.3

Administrative

3.5

(312.2)

1.3

(291.4)

Consolidated totals

$       6,860.0

$       1,063.5

$        6,358.2

$        1,060.5

Nine Months Ended September 30:

Paint Stores Group

$      10,955.7

$       2,490.7

$      10,478.8

$        2,412.0

Consumer Brands Group

2,829.2

556.3

2,341.7

453.4

Performance Coatings Group

5,522.9

760.9

5,153.1

698.1

Administrative

8.4

(952.1)

4.8

(864.3)

Consolidated totals

$      19,316.2

$       2,855.8

$      17,978.4

$        2,699.2

The Sherwin-Williams Company and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

(millions of dollars)

September 30,

2026

2025

Assets

Current assets:

Cash and cash equivalents

$          264.2

$          241.5

Accounts receivable, net

3,598.1

3,122.3

Inventories

2,547.0

2,276.3

Other current assets

618.1

506.0

Total current assets

7,027.4

6,146.1

Property, plant and equipment, net

4,225.6

3,913.2

Goodwill

7,975.5

7,794.1

Intangible assets

3,744.3

3,466.2

Operating lease right-of-use assets

2,101.5

1,989.5

Other assets

1,887.1

2,897.3

Total Assets

$      26,961.4

$      26,206.4

Liabilities and Shareholders' Equity

Current liabilities:

Short-term borrowings

$       2,353.6

$        1,846.9

Accounts payable

2,895.3

2,441.6

Compensation and taxes withheld

817.4

709.4

Accrued taxes

300.4

254.6

Current portion of long-term debt

1,498.8

350.5

Current portion of operating lease liabilities

487.6

479.8

Other accruals

1,495.8

1,390.7

Total current liabilities

9,848.9

7,473.5

Long-term debt

7,942.7

9,318.1

Postretirement benefits other than pensions

134.0

120.7

Deferred income taxes

742.4

657.2

Long-term operating lease liabilities

1,699.1

1,582.3

Other long-term liabilities

2,617.6

2,629.3

Shareholders' equity

3,976.7

4,425.3

Total Liabilities and Shareholders' Equity

$      26,961.4

$      26,206.4

Reconciliation of Non-GAAP Financial Measures

Management of the Company utilizes certain financial measures that are not in accordance with U.S. generally accepted accounting principles (US GAAP) to analyze and manage the performance of the business. Management provides non-GAAP information in reporting its financial results to give investors additional data to evaluate the Company's operations. Management does not, nor does it suggest investors should, consider such non-GAAP measures in isolation from, or in substitution for, financial information prepared in accordance with US GAAP.

Management believes that investors' understanding of the Company's operating performance is enhanced by the disclosure of diluted net income per share excluding Valspar acquisition-related amortization and certain other adjustments. Valspar acquisition-related amortization expense is excluded from diluted net income per share due to its significance as a result of the purchase price assigned to finite-lived intangible assets at the date of acquisition and the related impact on underlying business performance and trends. While these intangible assets contribute to the Company's revenue generation, the related revenue is not excluded. This adjusted diluted earnings per share measurement is not in accordance with US GAAP. It should not be considered a substitute for diluted earnings per share computed in accordance with US GAAP and may not be comparable to similarly titled measures reported by other companies. The following tables reconcile diluted net income per share computed in accordance with US GAAP to adjusted diluted net income per share.

Year Ending

Three Months Ended

Nine Months Ended

December 31, 2026

September 30, 2026

September 30, 2026

(after-tax guidance)

Pre-Tax

Tax

Effect (1)

After-
Tax

Pre-Tax

Tax

Effect (1)

After-
Tax

Low

High

Diluted net income per share

$   3.38

$   8.95

$  10.92

$  11.22

Acquisition-related amortization expense (2)

$    .27

$    .06

.21

$    .80

$    .19

.61

.82

.82

Severance and other restructuring expenses

.06

.02

.04

.15

.04

.11

.11

.11

Adjusted diluted net income per share

$   3.63

$   9.67

$  11.85

$  12.15

Three Months Ended

Nine Months Ended

Year Ended

September 30, 2025

September 30, 2025

December 31, 2025

Pre-Tax

Tax

Effect (1)

After-
Tax

Pre-Tax

Tax

Effect (1)

After-
Tax

Pre-Tax

Tax

Effect (1)

After-
Tax

Diluted net income per share

$   3.35

$   8.34

$ 10.26

Acquisition-related amortization expense (2)

$    .26

$    .06

.20

$    .77

$    .18

.59

$   1.03

$    .25

.78

Severance and other restructuring expenses

.06

.02

.04

.37

.10

.27

.44

.10

.34

Trademark impairment

—

—

—

—

—

—

.07

.02

.05

Adjusted diluted net income per share

$   3.59

$   9.20

$ 11.43

(1)

The tax effect is calculated based on the statutory rate and the nature of the item, unless otherwise noted.

(2)

Acquisition-related amortization expense, which is included within Selling, general and administrative expenses, consists of the amortization of intangible assets related to the Valspar acquisition. These intangible assets are primarily customer relationships and intellectual property and are being amortized over their remaining useful lives.

Management believes that investors' understanding of the Company's operating performance is enhanced by the disclosure of EBITDA, which is a non-GAAP financial measure defined as Net income before Interest expense, Income taxes, depreciation and amortization, as well as Adjusted EBITDA, which is a non-GAAP financial measure that excludes certain adjustments that management further believes enhances investors' understanding of the Company's operating performance. The reader is cautioned that the Company's EBITDA and Adjusted EBITDA should not be compared to other entities unknowingly. Further, EBITDA and Adjusted EBITDA should not be considered alternatives to Net income as an indicator of operating performance. The following table reconciles Net income computed in accordance with US GAAP to EBITDA and Adjusted EBITDA, as applicable.

(millions of dollars)

Three Months

Three Months

Three Months

Nine Months

Ended

Ended

Ended

Ended

March 31, 2026

June 30, 2026

September 30, 2026

September 30, 2026

Net income

$          534.7

$            843.6

$            821.0

$          2,199.3

Interest expense

131.6

135.9

139.3

406.8

Income taxes

145.1

268.9

242.5

656.5

Depreciation

98.3

98.5

99.2

296.0

Amortization

88.5

87.9

88.3

264.7

EBITDA

$          998.2

$          1,434.8

$          1,390.3

$          3,823.3

Severance and other restructuring expenses

—

23.8

13.1

36.9

Adjusted EBITDA

$          998.2

$          1,458.6

$          1,403.4

$          3,860.2

Three Months

Three Months

Three Months

Nine Months

Ended

Ended

Ended

Ended

March 31, 2025

June 30, 2025

September 30, 2025

September 30, 2025

Net income

$          503.9

$            754.7

$            833.1

$          2,091.7

Interest expense

103.8

112.4

117.2

333.4

Income taxes

149.1

231.0

227.4

607.5

Depreciation

79.9

79.3

82.8

242.0

Amortization

81.0

83.4

84.1

248.5

EBITDA

$          917.7

$          1,260.8

$          1,344.6

$          3,523.1

Severance and other restructuring expenses

19.3

59.0

14.4

92.7

Adjusted EBITDA

$          937.0

$          1,319.8

$          1,359.0

$          3,615.8

The Sherwin-Williams Company and Subsidiaries

Selected Information (Unaudited)

(millions of dollars, except store count data)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2026

2025

2026

2025

Depreciation

$        99.2

$        82.8

$      296.0

$      242.0

Capital expenditures

128.7

196.4

375.4

567.2

Cash dividends

194.3

195.7

588.9

594.0

Amortization of intangibles

88.3

84.1

264.7

248.5

Significant components of Other general expense (income) - net:

Provisions for environmental related matters - net

$        (0.1)

$        10.6

$         3.3

$        14.1

Loss (gain) on sale or disposition of assets

2.4

(23.8)

0.6

(27.2)

Other

2.9

8.5

11.0

23.6

Significant components of Other expense (income) - net:

Investment losses (gains)

$          —

$         3.9

$        (6.4)

$        (5.6)

Foreign currency transaction related losses - net

16.6

6.6

11.1

29.7

Other (1)

(10.6)

(8.2)

(14.8)

(14.2)

Store Count Data:

Paint Stores Group - net new stores

12

23

—

61

Paint Stores Group - total stores

4,853

4,834

4,853

4,834

Consumer Brands Group - net new stores

2

(8)

3

(30)

Consumer Brands Group - total stores

310

304

310

304

Performance Coatings Group - net new branches

—

—

—

—

Performance Coatings Group - total branches

317

324

317

324

(1) Consists of items of revenue, gains, expenses and losses unrelated to the primary business purpose of the Company.

SOURCE The Sherwin-Williams Company
2026-10-27 13:25 1d ago
2026-10-27 09:00 1d ago
Fortinet představuje FortiLink SASE pro malé pobočky
FTNT Fortinet
FMP Stock News 78
Original source text
FortiLink SASE service brings cloud-delivered security and centralized management to wired and wireless devices  | Source: Fortinet, Inc.

SUNNYVALE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced the FortiLink SASE Service, giving organizations a simpler way to secure small branch office, remote facilities, and other distributed locations without requiring a dedicated on-site firewall. By connecting local networks to FortiSASE, organizations can protect and manage wired and wireless devices through a simplified, cloud-delivered service while managing networking and security from a single console.

“Organizations need flexibility in how they secure distributed locations, particularly where dedicated security infrastructure or agents may not be practical,” said Anthony James, EVP of Marketing at Fortinet. “By extending FortiSASE to local networks, we're giving organizations a simpler way to protect users and devices while maintaining consistent security and centralized control.”

Simplifying Security Across Distributed Locations
Organizations operating small branch offices, remote facilities, and temporary sites often need to secure a mix of employee devices, printers, cameras, and IoT equipment with limited on-site IT resources. Many of these devices cannot run traditional endpoint security agents, while deploying dedicated firewalls at every location can introduce additional cost and complexity.

The FortiLink SASE Service addresses these challenges by connecting local networks to FortiSASE through supported Fortinet Wi-Fi access points and Ethernet switches. This gives organizations the flexibility to extend consistent security across distributed locations without requiring an on-site FortiGate firewall, while centralizing traffic inspection, policy enforcement, and management. Key benefits include:

Protect more devices: Secure wired and wireless devices, including those that cannot run FortiClient, through consistent cloud-delivered securitySimplify deployment: Connect entire LAN environments to FortiSASE without requiring endpoint agents on every device or dedicated security appliance at each locationCentralize management: Manage supported networking devices and security policies through a single console, reducing operational complexity across distributed environments
A Flexible Approach to Securing the Thin Edge
Built on Fortinet's unified networking and security architecture, the FortiLink SASE Service delivers consistent protection beyond individual endpoints to entire microbranch environments, giving organizations a simpler, scalable approach to securing distributed operations.

Learn more about simplifying security for microbranches and distributed locations in our blog.

Additional Resources

Learn how to secure thin edge deployments.Read about the Fortinet AI-Native Security Fabric.Learn about the Fortinet Open Ecosystem.Visit fortinet.com/trust to learn about Fortinet innovation, collaboration partners, product security processes, and enterprise-grade products.Read about how Fortinet customers are securing their organizations.Learn about Fortinet’s commitment to product security and integrity, including its responsible product development and vulnerability disclosure approach and policies.Follow Fortinet on X, LinkedIn, Facebook, and Instagram. Subscribe to Fortinet on our blog or YouTube.
Fortinet (Nasdaq: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices and data everywhere, and today we deliver cybersecurity everywhere our customers need it with the largest integrated portfolio of over 50 enterprise-grade products. Over one million lifetime customers trust Fortinet’s solutions, which are among the most deployed, most patented and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. Collaboration with esteemed organizations from both the public and private sectors, including Computer Emergency Response Teams (“CERTs”), government entities, and academia, is a fundamental aspect of Fortinet’s commitment to enhance cyber resilience globally. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog or FortiGuard Labs.

Copyright © 2026 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiCore, FortiMail, FortiSandbox, FortiADC, FortiAgent, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAppSec, FortiAuthenticator, FortiBranchSASE, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCART, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiDAST, FortiDATA, FortiDB, FortiDevice, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevice, FortiDevSec, FortiDLP, FortiEdge, FortiEDR, FortiEndpoint, FortiExplorer, FortiExtender, FortiFirewall, FortiFlex, FortiFone, FortiGSLB, FortiGuest, FortiHSM, FortiHypervisor, FortiIdentity, FortiInsight, FortiIsolator, FortiLink, FortiMonitor, FortiNAC, FortiNDR, FortiPAM, FortiPhish, FortiPoint, FortiPoints, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSAT, FortiSEC, FortiSIEM, FortiSMS, FortiSOAR, FortiSOC, FortiSRA, FortiSwitch, FortiTelemetry, FortiTester, FortiTIP, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM, FortiXDR, Lacework FortiCNAPP, Linksys, Intelligent Mesh, Velop, Max-Stream, Performance Perfected and SECURITY FABRIC.

Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.
2026-10-27 13:25 1d ago
2026-10-27 09:06 1d ago
Pentair překonal odhady EPS i tržeb
PNR Pentair
FMP Stock News 85
Original source text
Pentair plc (PNR - Free Report) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.24 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +10.28%. A quarter ago, it was expected that this company would post earnings of $1.12 per share when it actually produced earnings of $1.14, delivering a surprise of +1.79%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Pentair, which belongs to the Zacks Waste Removal Services industry, posted revenues of $976.4 million for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 1.33%. This compares to year-ago revenues of $1.02 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Pentair shares have lost about 47% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Pentair?While Pentair has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Pentair was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.21 on $1.06 billion in revenues for the coming quarter and $4.63 on $3.97 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Waste Removal Services is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

GFL Environmental Inc. (GFL - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2026. The results are expected to be released on October 28.

This company is expected to post quarterly earnings of $0.20 per share in its upcoming report, which represents a year-over-year change of +17.7%. The consensus EPS estimate for the quarter has been revised 9.9% lower over the last 30 days to the current level.

GFL Environmental Inc.'s revenues are expected to be $1.49 billion, up 20.9% from the year-ago quarter.
2026-10-27 13:24 1d ago
2026-10-27 04:50 1d ago
Diversify koupila 10 098 akcií společnosti Devon Energy
DVN Devon Energy
FMP Stock News 82
Original source text
Diversify Advisory Services LLC purchased a new stake in Devon Energy Corporation (NYSE:DVN – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,098 shares of the energy company’s stock, valued at approximately $497,000.

Several other institutional investors and hedge funds also recently made changes to their positions in DVN. Sigma Planning Corp lifted its position in Devon Energy by 3.5% in the 2nd quarter. Sigma Planning Corp now owns 6,902 shares of the energy company’s stock valued at $285,000 after acquiring an additional 233 shares in the last quarter. Retirement Planning Group LLC increased its holdings in Devon Energy by 4.5% during the 2nd quarter. Retirement Planning Group LLC now owns 5,647 shares of the energy company’s stock worth $233,000 after purchasing an additional 243 shares in the last quarter. JFS Wealth Advisors LLC raised its stake in shares of Devon Energy by 56.6% in the 2nd quarter. JFS Wealth Advisors LLC now owns 678 shares of the energy company’s stock valued at $28,000 after purchasing an additional 245 shares during the period. Titleist Asset Management LLC raised its stake in shares of Devon Energy by 5.7% in the 3rd quarter. Titleist Asset Management LLC now owns 5,556 shares of the energy company’s stock valued at $256,000 after purchasing an additional 298 shares during the period. Finally, Root Financial Partners LLC raised its stake in shares of Devon Energy by 33.2% in the 1st quarter. Root Financial Partners LLC now owns 1,219 shares of the energy company’s stock valued at $61,000 after purchasing an additional 304 shares during the period. Institutional investors and hedge funds own 69.72% of the company’s stock.

Insider Activity at Devon Energy In other news, CEO Clay Gaspar acquired 3,913 shares of the firm’s stock in a transaction on Monday, September 14th. The shares were purchased at an average cost of $51.08 per share, with a total value of $199,876.04. Following the acquisition, the chief executive officer directly owned 619,152 shares in the company, valued at $31,626,284.16. This represents a 0.64% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Ferrall Lowe III sold 6,756 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $50.95, for a total value of $344,218.20. Following the transaction, the executive vice president owned 72,720 shares in the company, valued at $3,705,084. The trade was a 8.50% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 4.58% of the company’s stock.

Devon Energy Stock Up 0.5% Devon Energy stock opened at $51.62 on Tuesday. The stock has a market cap of $56.79 billion, a P/E ratio of 12.26, a P/E/G ratio of 1.34 and a beta of 0.49. The company has a quick ratio of 0.67, a current ratio of 0.72 and a debt-to-equity ratio of 0.24. Devon Energy Corporation has a twelve month low of $31.65 and a twelve month high of $52.71. The company’s 50-day moving average price is $48.65 and its two-hundred day moving average price is $45.52. Devon Energy (NYSE:DVN – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The energy company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.17. Devon Energy had a net margin of 16.67% and a return on equity of 14.93%. The firm had revenue of $7.42 billion during the quarter, compared to the consensus estimate of $6.01 billion. During the same period last year, the business posted $0.84 earnings per share. The business’s revenue for the quarter was up 73.1% compared to the same quarter last year. As a group, analysts expect that Devon Energy Corporation will post 5.49 EPS for the current year.

Devon Energy Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Tuesday, September 15th. Devon Energy’s dividend payout ratio (DPR) is presently 30.40%.

Analyst Ratings Changes A number of research firms recently issued reports on DVN. Morgan Stanley increased their price objective on Devon Energy from $63.00 to $65.00 and gave the stock an “overweight” rating in a report on Thursday, October 15th. Argus restated a “buy” rating and issued a $45.85 target price on shares of Devon Energy in a research note on Monday, August 17th. Mizuho cut their target price on Devon Energy from $68.00 to $65.00 and set an “outperform” rating on the stock in a research note on Friday, October 16th. Wells Fargo & Company reduced their price target on Devon Energy from $65.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, September 28th. Finally, Susquehanna raised their price target on shares of Devon Energy from $57.00 to $63.00 and gave the stock a “positive” rating in a research note on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $60.72.

Get Our Latest Analysis on Devon Energy

About Devon Energy (Free Report)

Devon Energy Corporation (NYSE:DVN) is an independent energy company engaged primarily in the exploration, development and production of oil, natural gas and natural gas liquids. The company focuses on onshore operations in the United States and markets the hydrocarbons produced from its assets to customers across the energy sector.

Devon’s portfolio has historically included major U.S. resource plays such as the Delaware Basin in the Permian Basin, the Eagle Ford, the Anadarko Basin, the Williston Basin and the Powder River Basin.

Read More Five stocks we like better than Devon Energy Comfort Systems Earnings: AI Slowdown or More Growth Ahead? Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants Want to see what other hedge funds are holding DVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Devon Energy Corporation (NYSE:DVN – Free Report).

Receive News & Ratings for Devon Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Devon Energy and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 13:23 1d ago
2026-10-27 09:16 1d ago
Corning překonal odhady zisku i tržeb
GLW Corning
FMP Stock News 85
Original source text
Corning (GLW - Free Report) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.25%. A quarter ago, it was expected that this specialty glass maker would post earnings of $0.76 per share when it actually produced earnings of $0.78, delivering a surprise of +2.63%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Corning, which belongs to the Zacks Communication - Components industry, posted revenues of $5.08 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 1.04%. This compares to year-ago revenues of $4.27 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Corning shares have added about 45.9% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Corning?While Corning has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Corning was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.91 on $5.19 billion in revenues for the coming quarter and $3.30 on $19.09 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Communication - Components is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, ADTRAN Holdings (ADTN - Free Report) , has yet to report results for the quarter ended September 2026. The results are expected to be released on November 2.

This networking equipment maker is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -40%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

ADTRAN Holdings' revenues are expected to be $285.07 million, up 2% from the year-ago quarter.
2026-10-27 13:20 1d ago
2026-10-27 05:11 1d ago
Citizens Financial zvýšila svůj podíl ve společnosti Best Buy o 525,5 %
BBY Best Buy
FMP Stock News 82
Original source text
Citizens Financial Group Inc. RI raised its stake in Best Buy Co., Inc. (NYSE:BBY – Free Report) by 525.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,512 shares of the technology retailer’s stock after acquiring an additional 19,753 shares during the period. Citizens Financial Group Inc. RI’s holdings in Best Buy were worth $2,075,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Best Buy during the 2nd quarter valued at about $1,932,812,000. Bank of New York Mellon Corp acquired a new stake in shares of Best Buy during the second quarter worth approximately $174,893,000. KBC Group NV grew its stake in Best Buy by 50.5% in the first quarter. KBC Group NV now owns 1,584,803 shares of the technology retailer’s stock valued at $101,745,000 after purchasing an additional 531,998 shares in the last quarter. Deutsche Bank AG acquired a new position in Best Buy during the second quarter worth $116,003,000. Finally, Renaissance Technologies LLC raised its position in shares of Best Buy by 113.4% in the first quarter. Renaissance Technologies LLC now owns 1,449,439 shares of the technology retailer’s stock valued at $93,054,000 after purchasing an additional 770,339 shares during the period. Institutional investors and hedge funds own 80.96% of the company’s stock.

Insider Buying and Selling at Best Buy In other Best Buy news, EVP Kathleen Scarlett sold 116,062 shares of the business’s stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $92.15, for a total value of $10,695,113.30. Following the transaction, the executive vice president owned 116,173 shares in the company, valued at approximately $10,705,341.95. The trade was a 49.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Richard M. Schulze sold 300,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $92.51, for a total value of $27,753,000.00. The disclosure for this sale is available in the SEC filing. Company insiders own 0.50% of the company’s stock.

Best Buy Stock Down 1.9% Shares of NYSE BBY opened at $97.94 on Tuesday. The company has a market cap of $20.54 billion, a price-to-earnings ratio of 16.30, a PEG ratio of 2.50 and a beta of 1.26. The company has a current ratio of 1.12, a quick ratio of 0.41 and a debt-to-equity ratio of 0.36. The stock has a 50-day moving average price of $89.27 and a two-hundred day moving average price of $74.63. Best Buy Co., Inc. has a 12 month low of $55.10 and a 12 month high of $100.58. Best Buy (NYSE:BBY – Get Free Report) last issued its quarterly earnings data on Thursday, August 27th. The technology retailer reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.08. Best Buy had a return on equity of 48.14% and a net margin of 3.01%. The company had revenue of $9.78 billion during the quarter, compared to the consensus estimate of $9.59 billion. During the same period last year, the company earned $1.28 earnings per share. The firm’s revenue was up 3.6% compared to the same quarter last year. Best Buy has set its FY 2027 guidance at 6.700-6.900 EPS. As a group, analysts forecast that Best Buy Co., Inc. will post 6.81 earnings per share for the current fiscal year.

Best Buy Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Thursday, October 8th. Shareholders of record on Thursday, September 17th were issued a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 3.9%. The ex-dividend date of this dividend was Thursday, September 17th. Best Buy’s dividend payout ratio (DPR) is presently 63.89%.

Wall Street Analysts Forecast Growth BBY has been the topic of several research analyst reports. UBS Group restated a “neutral” rating and issued a $90.00 price target (up from $86.00) on shares of Best Buy in a research report on Friday, August 28th. Truist Financial set a $100.00 target price on shares of Best Buy in a research report on Thursday, August 27th. Evercore set a $95.00 price target on shares of Best Buy in a research report on Tuesday, October 20th. Barclays increased their target price on shares of Best Buy from $77.00 to $85.00 and gave the stock a “buy” rating in a report on Friday, August 28th. Finally, The Goldman Sachs Group raised their price objective on Best Buy from $62.00 to $71.00 and gave the stock a “sell” rating in a research note on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $85.90.

Get Our Latest Stock Report on Best Buy

About Best Buy (Free Report)

Best Buy Co, Inc is a specialty retailer of technology products and services headquartered in Richfield, Minnesota. The company sells consumer electronics, computing and mobile products, entertainment products, appliances, furniture, and related accessories through its retail stores, websites, and other sales channels.

Best Buy also provides technology-related services, including product installation, repair, technical support, delivery, and in-home consultation. Its services are offered through brands and operations such as Geek Squad, while the company also provides membership and protection programs designed to support customers after purchase.

The company serves customers primarily in the United States and Canada.

Read More Five stocks we like better than Best Buy Comfort Systems Earnings: AI Slowdown or More Growth Ahead? Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants

Receive News & Ratings for Best Buy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Best Buy and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 13:20 1d ago
2026-10-27 07:00 1d ago
Best Buy zahájí akci DoorBOOsters 30. října
BBY Best Buy
FMP Stock News 72
Original source text
-

Holiday shopping kicks off this Friday with a season full of weekly doorbusters, Black Friday deals, limited-time sales and gift ideas

MINNEAPOLIS--(BUSINESS WIRE)--The holiday season is just days away at Best Buy. The excitement officially starts this Friday, Oct. 30, with the return of DoorBOOsters™, kicking off a packed calendar of incredible deals. Shoppers can count on new Doorbusters dropping every week, major savings events through December and added rewards for My Best Buy Plus and Total™ members.

All season long, shoppers can find gifting inspiration in stores and online, whether that’s browsing the Holiday Gift Center, getting hands-on with store experiences or turning to the experts for advice. And with the Holiday Price Match Guarantee and an extended return window, they can check off their lists on their own time.

“Everyone does their holiday shopping a little differently. Some start in October and are done by Thanksgiving, and some don’t start until the last minute,” said Patrick McGinnis, chief revenue officer at Best Buy. “There are incredible gifts to give this year, so we wanted to make sure everyone has the right opportunities to find, choose, get and give the perfect gift, no matter their schedule.”

All the holiday deals

The holiday shopping season starts this weekend, and Best Buy is bringing shoppers more chances to save all season long.

DoorBOOsters: Halloween marks the official start of holiday savings at Best Buy, with doorbuster deals kicking off Oct. 30. It's customers’ first chance to get a jump on their holiday list, find something worth screaming about and maybe pick up a few treats while they're at it. Early Black Friday Deals and Doorbusters: The holiday savings pick up Nov. 6 with the arrival of Early Black Friday Deals and Doorbusters, giving shoppers an early jump on some of the season’s best offers. New deals will drop every Friday. Black Friday Doorbusters and Deals: Starting Nov. 19, Best Buy will offer 10 days of Black Friday Doorbusters and deals, giving shoppers plenty of time to find something for everyone on their lists. Cyber Sunday and Monday: The savings continue with our Cyber Sunday and Monday Sale Event, giving shoppers another opportunity to score a deal after Black Friday. Cyber Week Deals will run Dec. 1-6. Last-Minute Savings: Our Last-Minute Savings Event runs Dec. 18-24, so customers can make those final gift runs count. In addition, from Nov. 19 to Dec. 6, Plus and Total members earn double rewards on purchases.1 Members can also take advantage of exclusive offers throughout the season, including spend and get promotions, reward offers, and more

New tech to discover

The holidays are a great chance to discover what's next in tech. And there's plenty of new stuff hitting Best Buy stores this season.

From the latest Meta AI glasses to RGB LED TVs, there's always something new to see, try and experience. Add the latest gaming titles like Grand Theft Auto VI and The Legend of Zelda: Ocarina of Time; AI-powered Googlebooks and NVIDIA RTX Spark PCs; wearable tech like Oura Ring 5; and more. A trip to Best Buy can be as much about discovering what's new as it is about checking something off a list.

Simple holiday shopping

To ensure a seamless experience, Best Buy is bringing customers a variety of ways to shop, save and exchange all season long.

Holiday Gift Center: Our Holiday Gift Center makes gift shopping easy with curated gift guides, expert recommendations and inspiration for everyone on their list. Price Match: Our Holiday Price Match Guarantee makes sure customers don’t miss out on savings. If the price of a product sold by Best Buy drops during the holiday season, we’ll match it.2 Extended Store Hours: Starting Nov. 1, we’re making it even easier to discover the latest tech, shop deals and get expert advice with extended store hours. Customers can find updated hours on their local store page. Plus, they can take advantage of store pickup or 24/7 Pickup Lockers at select stores to grab their orders whenever it’s convenient. Returns and Exchanges: Easy returns allow customers to shop with peace of mind. Best Buy’s Extended Holiday Return and Exchange Policy means most purchases made Oct. 30 through Dec. 31 can be returned through Jan. 15, 2027, and Jan. 31, 2027 for Plus and Total members. 3 Stores will be closed on Thanksgiving Day, but as always, shoppers can take advantage of great deals in the Best Buy app and on BestBuy.com.

More News From Best Buy Co., Inc.

Back to Newsroom
2026-10-27 13:19 1d ago
2026-10-27 05:16 1d ago
Insider společnosti UiPath prodal 29 565 akcií PATH
PATH UiPath
FMP Stock News 78
Original source text
UiPath, Inc. (NYSE:PATH – Get Free Report) insider Raghavendra Malpani sold 29,565 shares of the stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $14.00, for a total transaction of $413,910.00. Following the completion of the sale, the insider owned 1,484,716 shares of the company’s stock, valued at $20,786,024. This trade represents a 1.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Raghavendra Malpani also recently made the following trade(s):

On Friday, October 9th, Raghavendra Malpani sold 29,564 shares of UiPath stock. The stock was sold at an average price of $13.51, for a total transaction of $399,409.64. On Thursday, September 17th, Raghavendra Malpani sold 40,464 shares of UiPath stock. The shares were sold at an average price of $14.00, for a total transaction of $566,496.00. UiPath Trading Up 1.3% Shares of NYSE PATH opened at $14.32 on Tuesday. The stock has a market cap of $7.46 billion, a PE ratio of 21.37, a P/E/G ratio of 1.33 and a beta of 1.01. UiPath, Inc. has a 12-month low of $9.20 and a 12-month high of $19.84. The company has a 50-day moving average of $14.46 and a 200 day moving average of $12.50.

UiPath (NYSE:PATH – Get Free Report) last released its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The business had revenue of $410.26 million for the quarter, compared to analyst estimates of $397.77 million. During the same period last year, the company posted $0.15 EPS. The business’s revenue was up 13.3% on a year-over-year basis. On average, sell-side analysts forecast that UiPath, Inc. will post 0.49 EPS for the current fiscal year. Analyst Upgrades and Downgrades A number of equities analysts recently commented on the company. Weiss Ratings upgraded UiPath from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 9th. BMO Capital Markets dropped their target price on UiPath from $18.00 to $15.00 and set a “market perform” rating for the company in a report on Thursday, September 24th. TD Cowen restated a “hold” rating and issued a $16.00 target price on shares of UiPath in a report on Wednesday, September 23rd. Barclays raised their target price on UiPath from $14.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Friday, September 4th. Finally, Mizuho lifted their price target on UiPath from $12.00 to $14.00 and gave the stock a “neutral” rating in a report on Friday, September 4th. Four investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, UiPath presently has a consensus rating of “Hold” and an average target price of $15.69.

Read Our Latest Stock Analysis on PATH

Institutional Trading of UiPath Several hedge funds have recently made changes to their positions in PATH. BlackRock Inc. raised its position in shares of UiPath by 7.2% during the 2nd quarter. BlackRock Inc. now owns 46,153,124 shares of the company’s stock valued at $501,684,000 after buying an additional 3,097,822 shares during the period. Squarepoint Ops LLC grew its position in UiPath by 8,065.7% in the second quarter. Squarepoint Ops LLC now owns 1,497,555 shares of the company’s stock worth $16,278,000 after acquiring an additional 1,516,355 shares during the period. Dimensional Fund Advisors LP grew its position in UiPath by 26.7% in the first quarter. Dimensional Fund Advisors LP now owns 6,831,288 shares of the company’s stock worth $75,818,000 after acquiring an additional 1,437,843 shares during the period. Bank of America Corp DE increased its stake in UiPath by 13.2% during the first quarter. Bank of America Corp DE now owns 10,046,699 shares of the company’s stock worth $111,518,000 after acquiring an additional 1,170,285 shares during the last quarter. Finally, Corient Private Wealth LP increased its stake in UiPath by 398.4% during the second quarter. Corient Private Wealth LP now owns 708,146 shares of the company’s stock worth $7,698,000 after acquiring an additional 566,074 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

About UiPath (Get Free Report)

UiPath, Inc develops enterprise automation software that helps organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation with artificial intelligence, workflow orchestration, process mining, document processing and application integration capabilities.

The company’s products are designed to support the discovery, development, deployment and management of software robots and AI-powered automations across functions such as finance, customer service, human resources, information technology and operations.

Read More Five stocks we like better than UiPath Comfort Systems Earnings: AI Slowdown or More Growth Ahead? Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
2026-10-27 13:18 1d ago
2026-10-27 07:23 1d ago
Broadcom získal financování ve výši 63 miliard USD na hardware pro AI pro Anthropic
BX Blackstone Group
FMP Stock News 94
Original source text
Broadcom Lands Massive $63 Billion AI Financing Deal After Tense Bank Talks Summary

Broadcom shares advanced after lenders backed a $63 billion financing package designed to fund AI hardware that Anthropic will lease

Broadcom AVGO shares rose 1.5% early Tuesday trading after a $63 billion financing deal to fund artificial intelligence equipment for Anthropic moved forward.

The financing will allow a newly formed special-purpose vehicle to purchase Broadcom's AI accelerators and networking equipment, then lease the hardware to Anthropic, the developer of the Claude AI assistant. Deliveries are expected to begin in 2027 under an existing computing-capacity agreement.

Bank of America BAC, Citigroup (C) and Morgan Stanley MS are arranging the senior, first-lien loans, while Blackstone (BX) will provide the committed second-lien financing. Broadcom will offer residual-value support for the senior portion, helping protect lenders if the equipment loses value.

The deal followed weeks of negotiations, with some lenders reportedly questioning whether the returns justified the risks. Broadcom Chief Executive Hock Tan held weekend discussions with bank executives and agreed to higher borrowing costs to secure their participation, The Wall Street Journal reported.

The agreement highlights how major AI developers are using debt financing to secure computing capacity as demand for advanced chips grows. Anthropic also filed for an initial public offering on Monday, adding another major funding milestone to its expansion plans.

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure
2026-10-27 13:10 1d ago
2026-10-27 08:00 1d ago
Enphase představila transformátor pro datová centra s AI
ENPH Enphase Energy
FMP Stock News 94
Original source text
FREMONT, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced a major milestone in the development of its IQ® Solid-State Transformer (IQ SST), successfully demonstrating 13.8 kV AC to 800 VDC conversion at its research and development lab in Austin, Texas. The test system consisted of 132 power modules, with 44 connected in series on each of three phases, operating together as a single system. The system maintained a stable 800 VDC output through load steps simulating the fast-changing demands of AI compute racks.

"Over the past 20 years, we've built and shipped nearly 90 million microinverters, gaining extensive experience in designing and manufacturing reliable power electronics,” said Raghu Belur, co-founder and chief product officer at Enphase Energy. "IQ SST brings that same approach to AI data centers, moving us closer to delivering power more efficiently to AI compute racks."

By converting medium-voltage AC directly to 800 VDC, IQ SST is designed to eliminate multiple conversion stages in conventional data center power architectures, reducing conversion losses and making more power available for AI compute.

In the demonstration, each power module handled a few hundred volts, so no single module saw the full 13.8 kV. Enphase's distributed controls maintained balanced voltage sharing across all 132 modules and coordinated their response to rapid load changes, keeping the output within specification. Redundancy is also built into the architecture. IQ SST is designed to continue operating if an individual power module fails.

"The system performed exactly as designed," said Hans van Antwerpen, chief technology officer at Enphase Energy. "All 132 modules shared the voltage evenly, and the 800 V output held steady through every load step. The architecture scales by adding power modules in series, so 13.8 kV gives us a clear path to 34.5 kV."

Each 5.5 kW-rated power module combines gallium nitride (GaN) power switching, Enphase's fifth-generation Kestrel ASIC, and a proprietary high-frequency transformer developed by Enphase's in-house magnetics team. The modules use similar components and manufacturing processes to those used in Enphase IQ Microinverters, and the first IQ SST power modules are already being built at Enphase's manufacturing facility in Arlington, Texas.

Building on this achievement, Enphase plans to extend the demonstration to 34.5 kV in the coming weeks, leveraging the scalability of its modular architecture. We expect to demonstrate full-system IQ SST racks operating at megawatt scale and rated power before the end of 2026, with customer pilots planned for 2027. To learn more about IQ SST, visit the Enphase website.

About Enphase Energy, Inc.

Enphase Energy is a global energy technology company advancing intelligent power systems for homes, businesses, and next-generation AI data centers. The company designs semiconductor-based energy technologies spanning solar, batteries, EV charging, energy management, and virtual power plants, and is developing solid-state transformer technology to address the rapidly growing power demands of AI data centers. Based in Fremont, California, Enphase is the world’s leading supplier of microinverter-based solar and battery systems. The company revolutionized the solar industry with its microinverter technology and has shipped approximately 89.4 million microinverters, with approximately 5.3 million Enphase-based systems deployed in more than 165 countries. Enphase products enable people to harness the sun to make, use, save, and sell their own power, all controlled through the Enphase App. For more information, visit https://enphase.com/.

©2026 Enphase Energy, Inc. All rights reserved. Enphase Energy, Enphase, the “e” logo, IQ, and certain other marks listed at https://enphase.com/trademark-usage-guidelines are trademarks or service marks of Enphase Energy, Inc. Other names are for informational purposes and may be trademarks of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements, including statements related to the expected capabilities and performance of Enphase Energy's IQ SST, including safety, quality, reliability, scalability, efficiency, redundancy, and medium-voltage power conversion capabilities; the expected benefits of IQ SST, including reduced power conversion losses, increased power available for AI compute, and support for AI data center applications; the expected performance and benefits of Enphase's distributed architecture, gallium nitride (GaN) technology, Kestrel ASIC, and power modules; the manufacture of IQ SST power modules at Enphase's U.S. manufacturing facilities; and the timing of future demonstrations, product development milestones, and customer pilot programs. These forward-looking statements are based on Enphase Energy's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. Such risks include, but are not limited to, technological development and validation risks; market demand for AI data center infrastructure and related products; competitive developments; the ability to achieve anticipated performance, reliability, scalability, and efficiency objectives; manufacturing and supply chain availability and costs; the successful completion of future testing, demonstrations, and pilot programs; changes in regulatory or compliance requirements; and other factors discussed in Enphase Energy's filings with the Securities and Exchange Commission, including those risks described in more detail in Enphase Energy's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other filings made from time to time with the Securities and Exchange Commission. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations, except as required by law.

Contact:

Enphase Energy
[email protected]
2026-10-27 13:07 1d ago
2026-10-27 08:45 1d ago
Travel + Leisure překonala odhady EPS i tržeb
TNL Travel + Leisure
FMP Stock News 85
Original source text
Travel + Leisure Co. (TNL - Free Report) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $1.8 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +8.33%. A quarter ago, it was expected that this company would post earnings of $1.93 per share when it actually produced earnings of $1.88, delivering a surprise of -2.59%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Travel Leisure Co., which belongs to the Zacks Leisure and Recreation Services industry, posted revenues of $1.1 billion for the quarter ended September 2026, surpassing the Zacks Consensus Estimate by 0.09%. This compares to year-ago revenues of $1.04 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Travel Leisure Co. shares have lost about 7% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Travel Leisure Co.?While Travel Leisure Co. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Travel Leisure Co. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.23 on $1.08 billion in revenues for the coming quarter and $7.47 on $4.2 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Services is currently in the bottom 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Giftify, Inc. (GIFT - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2026.

This company is expected to post quarterly loss of $0.02 per share in its upcoming report, which represents a year-over-year change of +75%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Giftify, Inc.'s revenues are expected to be $22.01 million, up 17.2% from the year-ago quarter.